Panacea Index Logo

Command Palette

Search for a command to run...

247
573
105
247 (27%)
573 (62%)
105 (11%)

Evidence suggests Vegan Diet maydecreaseCholesterol.

423 studies (925 claims)

Moderate consensus

Study Claims

888 of 937
InterventionDirectionEndpointTypePopulationDosageTitle
Human
adolescent females with polycystic ovary syndromePersonalized MD plans delivered every 15 days via CDSS (specific dietary amounts not detailed).Optimizing Dietary Habits in Adolescents with Polycystic Ovary Syndrome: Personalized Mediterranean Diet Intervention via Clinical Decision Support System-A Randomized Controlled Trial.
Human
postmenopausal obese womenLA treatment for 30 minutes, three times a week.The effects of laser acupuncture on metabolic syndrome in obese postmenopausal women: a randomized controlled study.
Human
postmenopausal obese womenLA treatment for 30 minutes, three times a week.The effects of laser acupuncture on metabolic syndrome in obese postmenopausal women: a randomized controlled study.
Human
individuals with or at risk for metabolic syndrome60 g/day (incorporated into smoothies twice daily for a 3000-kcal diet).Diets Low in Saturated Fat with Different Unsaturated Fatty Acid Profiles Similarly Increase Serum-Mediated Cholesterol Efflux from THP-1 Macrophages in a Population with or at Risk for Metabolic Syndrome: The Canola Oil Multicenter Intervention Trial.
Human
individuals with or at risk for metabolic syndrome60 g/day (incorporated into smoothies twice daily for a 3000-kcal diet).Diets Low in Saturated Fat with Different Unsaturated Fatty Acid Profiles Similarly Increase Serum-Mediated Cholesterol Efflux from THP-1 Macrophages in a Population with or at Risk for Metabolic Syndrome: The Canola Oil Multicenter Intervention Trial.
Human
individuals with or at risk for metabolic syndrome60 g/day (incorporated into smoothies twice daily for a 3000-kcal diet).Diets Low in Saturated Fat with Different Unsaturated Fatty Acid Profiles Similarly Increase Serum-Mediated Cholesterol Efflux from THP-1 Macrophages in a Population with or at Risk for Metabolic Syndrome: The Canola Oil Multicenter Intervention Trial.
Human
individuals with or at risk for metabolic syndrome60 g/day (incorporated into smoothies twice daily for a 3000-kcal diet).Diets Low in Saturated Fat with Different Unsaturated Fatty Acid Profiles Similarly Increase Serum-Mediated Cholesterol Efflux from THP-1 Macrophages in a Population with or at Risk for Metabolic Syndrome: The Canola Oil Multicenter Intervention Trial.
Human
individuals with or at risk for metabolic syndrome60 g/day (incorporated into smoothies twice daily for a 3000-kcal diet).Diets Low in Saturated Fat with Different Unsaturated Fatty Acid Profiles Similarly Increase Serum-Mediated Cholesterol Efflux from THP-1 Macrophages in a Population with or at Risk for Metabolic Syndrome: The Canola Oil Multicenter Intervention Trial.
Animal
obese Wister male ratsRSV at 30 mg/kg/dayRole of trans-resveratrol in ameliorating biochemical and molecular alterations in obese rats induced by a high fructose/fat diet.
Animal
obese Wister male ratsRSV at 30 mg/kg/dayRole of trans-resveratrol in ameliorating biochemical and molecular alterations in obese rats induced by a high fructose/fat diet.
Human
overweight and obese adultsNot specified (calorie-restricted, low-fat diets).Effects of a vegetarian diet and treatment preference on biochemical and dietary variables in overweight and obese adults: a randomized clinical trial.
Human
fifteen normal-weight men50% fat diet rich in either CSO or OO.A 5-day high-fat diet rich in cottonseed oil improves cholesterol profiles and triglycerides compared to olive oil in healthy men.
Human
fifteen normal-weight men50% fat diet rich in either CSO or OO.A 5-day high-fat diet rich in cottonseed oil improves cholesterol profiles and triglycerides compared to olive oil in healthy men.
Human
fifteen normal-weight men50% fat diet rich in either CSO or OO.A 5-day high-fat diet rich in cottonseed oil improves cholesterol profiles and triglycerides compared to olive oil in healthy men.
Human
children and adolescents with dyslipidemiaNot specifiedEffect of phytosterol capsule supplementation associated with the National Cholesterol Education Program Step 2 diet on low-density lipoprotein in children and adolescents with dyslipidemia: A double-blind crossover trial.
Animal
An egg-enriched diet attenuates plasma lipids and mediates cholesterol metabolism of high-cholesterol fed rats.
Animal
An egg-enriched diet attenuates plasma lipids and mediates cholesterol metabolism of high-cholesterol fed rats.
Animal
Sprague-Dawley ratsAn egg-enriched diet attenuates plasma lipids and mediates cholesterol metabolism of high-cholesterol fed rats.
Animal
Sprague-Dawley ratsAn egg-enriched diet attenuates plasma lipids and mediates cholesterol metabolism of high-cholesterol fed rats.
Animal
Sprague-Dawley ratsAn egg-enriched diet attenuates plasma lipids and mediates cholesterol metabolism of high-cholesterol fed rats.
Animal
Sprague-Dawley ratsAn egg-enriched diet attenuates plasma lipids and mediates cholesterol metabolism of high-cholesterol fed rats.
Human
2 g of plant sterol esters per day, administered via liquid yoghurt.Effect of plant sterols on the lipid profile of patients with hypercholesterolaemia. Randomised, experimental study.
Animal
exercising Thoroughbred horsesApproximately 12% of digestible energy (DE) from the oil source for 10 months, then increased to 20% DE for an additional 6 months.Effect of feeding thoroughbred horses a high unsaturated or saturated vegetable oil supplemented diet for 6 months following a 10 month fat acclimation.
Animal
exercising Thoroughbred horsesApproximately 12% of digestible energy (DE) from the oil source for 10 months, then increased to 20% DE for an additional 6 months.Effect of feeding thoroughbred horses a high unsaturated or saturated vegetable oil supplemented diet for 6 months following a 10 month fat acclimation.
Animal
exercising Thoroughbred horsesApproximately 12% of digestible energy (DE) from the oil source for 10 months, then increased to 20% DE for an additional 6 months.Effect of feeding thoroughbred horses a high unsaturated or saturated vegetable oil supplemented diet for 6 months following a 10 month fat acclimation.
Human
overweight/obese individuals in Southwest ChinaDaily energy intake reduced by 300-500 kcal, with low-glycemic index carbohydrate-energy ratio <45% and fat-energy ratio 25-30%.Fat-restricted low-glycemic index diet controls weight and improves blood lipid profile: A pilot study among overweight and obese adults in Southwest China.
Human
overweight/obese Southwest Chinese individualsDaily energy intake reduced by 300-500 kcal, with low-glycemic index carbohydrate-energy ratio <45% and fat-energy ratio 25-30%.Fat-restricted low-glycemic index diet controls weight and improves blood lipid profile: A pilot study among overweight and obese adults in Southwest China.
Human
Not specifiedVegetarian diet, blood pressure and cardiovascular risk.
Human
Not specifiedVegetarian diet, blood pressure and cardiovascular risk.
Human
random sample of forty-seven Adventist vegetariansNot specifiedVegetarian diet, blood pressure and cardiovascular risk.
Human
Not availableNutrition of vegetarians in Poland – a review of research.
Human
subjects with ischemic heart diseaseIndividually designed isocaloric diet plans (specific amounts not detailed).Effects of a Vegetarian Diet on Cardiometabolic Risk Factors, Gut Microbiota, and Plasma Metabolome in Subjects With Ischemic Heart Disease: A Randomized, Crossover Study.
Human
subjects with ischemic heart diseaseIndividually designed isocaloric diet plans (specific amounts not detailed).Effects of a Vegetarian Diet on Cardiometabolic Risk Factors, Gut Microbiota, and Plasma Metabolome in Subjects With Ischemic Heart Disease: A Randomized, Crossover Study.
Human
subjects with ischemic heart diseaseIndividually designed isocaloric diet plans (specific amounts not detailed).Effects of a Vegetarian Diet on Cardiometabolic Risk Factors, Gut Microbiota, and Plasma Metabolome in Subjects With Ischemic Heart Disease: A Randomized, Crossover Study.
Human
subjects with ischemic heart diseaseIndividually designed isocaloric diet plans (specific amounts not detailed).Effects of a Vegetarian Diet on Cardiometabolic Risk Factors, Gut Microbiota, and Plasma Metabolome in Subjects With Ischemic Heart Disease: A Randomized, Crossover Study.
Human
overweight individuals20 mL of coconut oil per day.The effect of coconut oil on anthropometric measurements and irisin levels in overweight individuals.
Human
overweight individuals20 mL of coconut oil per day.The effect of coconut oil on anthropometric measurements and irisin levels in overweight individuals.
Animal
Male Wistar rats250 mg/kg administered intraperitoneally.Effects of carnosine supplementation on markers for the pathophysiological development of metabolic dysfunction-associated steatotic liver disease in a diet-induced model.
Animal
Male Wistar rats250 mg/kg administered intraperitoneally.Effects of carnosine supplementation on markers for the pathophysiological development of metabolic dysfunction-associated steatotic liver disease in a diet-induced model.
Human
control groupNot specified (dietary intervention only)[Influence of combined lacto-vegetarian diet and selective beta-blocking agents on clinical and metabolic indices in patients with coronary heart disease].
Human
vegetarian groupNot specified (dietary intervention only)[Influence of combined lacto-vegetarian diet and selective beta-blocking agents on clinical and metabolic indices in patients with coronary heart disease].
Human
vegetarian groupNot specified (dietary intervention only)[Influence of combined lacto-vegetarian diet and selective beta-blocking agents on clinical and metabolic indices in patients with coronary heart disease].
Human
vegetarian groupNot specified (dietary intervention only)[Influence of combined lacto-vegetarian diet and selective beta-blocking agents on clinical and metabolic indices in patients with coronary heart disease].
Animal
cynomolgus monkeys3.4% soy lecithin in diet.Soy lecithin reduces plasma lipoprotein cholesterol and early atherogenesis in hypercholesterolemic monkeys and hamsters: beyond linoleate.
Animal
cynomolgus monkeys3.4% soy lecithin in diet.Soy lecithin reduces plasma lipoprotein cholesterol and early atherogenesis in hypercholesterolemic monkeys and hamsters: beyond linoleate.
Animal
cynomolgus monkeys3.4% soy lecithin in diet.Soy lecithin reduces plasma lipoprotein cholesterol and early atherogenesis in hypercholesterolemic monkeys and hamsters: beyond linoleate.
Animal
cynomolgus monkeys3.4% soy lecithin in diet.Soy lecithin reduces plasma lipoprotein cholesterol and early atherogenesis in hypercholesterolemic monkeys and hamsters: beyond linoleate.
Human
overweight and obese retired miners with lipid disorders1 hour of Nordic walking 3 times per week at 60-70% of maximal heart rate.Effect of 12-Week Interventions Involving Nordic Walking Exercise and a Modified Diet on the Anthropometric Parameters and Blood Lipid Profiles in Overweight and Obese Ex-Coal Miners.
Human
Subjects (n 9)Four isoenergetic diets varying in calcium (700 mg/d or 2800 mg/d) and fat (25% or 49% of energy).Dairy calcium intake modifies responsiveness of fat metabolism and blood lipids to a high-fat diet.
Human
Subjects (n 9)Four isoenergetic diets varying in calcium (700 mg/d or 2800 mg/d) and fat (25% or 49% of energy).Dairy calcium intake modifies responsiveness of fat metabolism and blood lipids to a high-fat diet.
Human
Subjects (n 9)Four isoenergetic diets varying in calcium (700 mg/d or 2800 mg/d) and fat (25% or 49% of energy).Dairy calcium intake modifies responsiveness of fat metabolism and blood lipids to a high-fat diet.
Human
Subjects (n 9)Four isoenergetic diets varying in calcium (700 mg/d or 2800 mg/d) and fat (25% or 49% of energy).Dairy calcium intake modifies responsiveness of fat metabolism and blood lipids to a high-fat diet.
Human
Subjects (n 9)Four isoenergetic diets varying in calcium (700 mg/d or 2800 mg/d) and fat (25% or 49% of energy).Dairy calcium intake modifies responsiveness of fat metabolism and blood lipids to a high-fat diet.
Human
Subjects (n 9)Four isoenergetic diets varying in calcium (700 mg/d or 2800 mg/d) and fat (25% or 49% of energy).Dairy calcium intake modifies responsiveness of fat metabolism and blood lipids to a high-fat diet.
Human
Subjects (n 9)Four isoenergetic diets varying in calcium (700 mg/d or 2800 mg/d) and fat (25% or 49% of energy).Dairy calcium intake modifies responsiveness of fat metabolism and blood lipids to a high-fat diet.
Animal
Dietary effects of diacylglycerol rich mustard oil on lipid profile of normocholesterolemic and hypercholesterolemic rats.
Animal
Dietary effects of diacylglycerol rich mustard oil on lipid profile of normocholesterolemic and hypercholesterolemic rats.
Human
overweight and obese womenNot specifiedImpact of Diets Rich in Whole Grains and Fruits and Vegetables on Cardiovascular Risk Factors in Overweight and Obese Women: A Randomized Clinical Feeding Trial.
Human
overweight and obese womenNot specifiedImpact of Diets Rich in Whole Grains and Fruits and Vegetables on Cardiovascular Risk Factors in Overweight and Obese Women: A Randomized Clinical Feeding Trial.
Human
overweight and obese womenNot specifiedImpact of Diets Rich in Whole Grains and Fruits and Vegetables on Cardiovascular Risk Factors in Overweight and Obese Women: A Randomized Clinical Feeding Trial.
Human
overweight and obese womenNot specifiedImpact of Diets Rich in Whole Grains and Fruits and Vegetables on Cardiovascular Risk Factors in Overweight and Obese Women: A Randomized Clinical Feeding Trial.
Human
overweight and obese womenNot specifiedImpact of Diets Rich in Whole Grains and Fruits and Vegetables on Cardiovascular Risk Factors in Overweight and Obese Women: A Randomized Clinical Feeding Trial.
Human
overweight and obese womenNot specifiedImpact of Diets Rich in Whole Grains and Fruits and Vegetables on Cardiovascular Risk Factors in Overweight and Obese Women: A Randomized Clinical Feeding Trial.
Human
overweight and obese adults84 g/day of almonds.Almonds vs complex carbohydrates in a weight reduction program.
Human
overweight and obese adults84 g/day of almonds.Almonds vs complex carbohydrates in a weight reduction program.
Human
overweight, obese, and healthy-weight femalesLess than 30 g of carbohydrates, approximately 60 g of protein, and 140 g of fat per day (80% unsaturated and 20% saturated fat).Effects of a 12 Week Ketogenic Diet Intervention on Obese and Overweight Females with Glucose and Lipid Metabolism Disturbance.
Human
total study populationDiets differed by ~9 energy percent (E%) in SFA and ~4 E% in PUFA between groups.BMI modifies the effect of dietary fat on atherogenic lipids: a randomized clinical trial.
Human
normal-weight participantsDiets differed by ~9 energy percent (E%) in SFA and ~4 E% in PUFA between groups.BMI modifies the effect of dietary fat on atherogenic lipids: a randomized clinical trial.
Human
obese participantsDiets differed by ~9 energy percent (E%) in SFA and ~4 E% in PUFA between groups.BMI modifies the effect of dietary fat on atherogenic lipids: a randomized clinical trial.
Human
total study populationDiets differed by ~9 energy percent (E%) in SFA and ~4 E% in PUFA between groups.BMI modifies the effect of dietary fat on atherogenic lipids: a randomized clinical trial.
Human
normal-weight participantsDiets differed by ~9 energy percent (E%) in SFA and ~4 E% in PUFA between groups.BMI modifies the effect of dietary fat on atherogenic lipids: a randomized clinical trial.
Human
obese participantsDiets differed by ~9 energy percent (E%) in SFA and ~4 E% in PUFA between groups.BMI modifies the effect of dietary fat on atherogenic lipids: a randomized clinical trial.
Animal
rat liversNot specifiedPomegranate seed oil and bitter melon extract supplemented in diet influence the lipid profile and intensity of peroxidation in livers of SPRD rats exposed to a chemical carcinogen.
Animal
twelve male obese Zucker fa/fa ratsWater-soluble protein from blue whiting as 1/3 of total protein, with the remaining 2/3 as casein.Water-Soluble Fish Protein Intake Led to Lower Serum and Liver Cholesterol Concentrations in Obese Zucker fa/fa Rats.
Animal
twelve male obese Zucker fa/fa ratsWater-soluble protein from blue whiting as 1/3 of total protein, with the remaining 2/3 as casein.Water-Soluble Fish Protein Intake Led to Lower Serum and Liver Cholesterol Concentrations in Obese Zucker fa/fa Rats.
Animal
twelve male obese Zucker fa/fa ratsWater-soluble protein from blue whiting as 1/3 of total protein, with the remaining 2/3 as casein.Water-Soluble Fish Protein Intake Led to Lower Serum and Liver Cholesterol Concentrations in Obese Zucker fa/fa Rats.
Animal
twelve male obese Zucker fa/fa ratsWater-soluble protein from blue whiting as 1/3 of total protein, with the remaining 2/3 as casein.Water-Soluble Fish Protein Intake Led to Lower Serum and Liver Cholesterol Concentrations in Obese Zucker fa/fa Rats.
Animal
twelve male obese Zucker fa/fa ratsWater-soluble protein from blue whiting as 1/3 of total protein, with the remaining 2/3 as casein.Water-Soluble Fish Protein Intake Led to Lower Serum and Liver Cholesterol Concentrations in Obese Zucker fa/fa Rats.
Animal
twelve male obese Zucker fa/fa ratsWater-soluble protein from blue whiting as 1/3 of total protein, with the remaining 2/3 as casein.Water-Soluble Fish Protein Intake Led to Lower Serum and Liver Cholesterol Concentrations in Obese Zucker fa/fa Rats.
Animal
obese Zucker fa/fa ratsWater-soluble protein from blue whiting as 1/3 of total protein, with the remaining 2/3 as casein.Water-Soluble Fish Protein Intake Led to Lower Serum and Liver Cholesterol Concentrations in Obese Zucker fa/fa Rats.
Animal
obese Zucker fa/fa ratsWater-soluble protein from blue whiting as 1/3 of total protein, with the remaining 2/3 as casein.Water-Soluble Fish Protein Intake Led to Lower Serum and Liver Cholesterol Concentrations in Obese Zucker fa/fa Rats.
Animal
twelve male obese Zucker fa/fa ratsWater-soluble protein from blue whiting as 1/3 of total protein, with the remaining 2/3 as casein.Water-Soluble Fish Protein Intake Led to Lower Serum and Liver Cholesterol Concentrations in Obese Zucker fa/fa Rats.
Animal
twelve male obese Zucker fa/fa ratsWater-soluble protein from blue whiting as 1/3 of total protein, with the remaining 2/3 as casein.Water-Soluble Fish Protein Intake Led to Lower Serum and Liver Cholesterol Concentrations in Obese Zucker fa/fa Rats.
Animal
obese Zucker fa/fa ratsWater-soluble protein from blue whiting as 1/3 of total protein, with the remaining 2/3 as casein.Water-Soluble Fish Protein Intake Led to Lower Serum and Liver Cholesterol Concentrations in Obese Zucker fa/fa Rats.
Animal
obese Zucker fa/fa ratsWater-soluble protein from blue whiting as 1/3 of total protein, with the remaining 2/3 as casein.Water-Soluble Fish Protein Intake Led to Lower Serum and Liver Cholesterol Concentrations in Obese Zucker fa/fa Rats.
Animal
twelve male obese Zucker fa/fa ratsWater-soluble protein from blue whiting as 1/3 of total protein, with the remaining 2/3 as casein.Water-Soluble Fish Protein Intake Led to Lower Serum and Liver Cholesterol Concentrations in Obese Zucker fa/fa Rats.
Animal
twelve male obese Zucker fa/fa ratsWater-soluble protein from blue whiting as 1/3 of total protein, with the remaining 2/3 as casein.Water-Soluble Fish Protein Intake Led to Lower Serum and Liver Cholesterol Concentrations in Obese Zucker fa/fa Rats.
Human
92 men and women with abdominal obesity and relatively low HDL-cholesterol concentrationsSFAs from butter constituted 12.4-12.6% of total calories in the diet.Comparison of the impact of SFAs from cheese and butter on cardiometabolic risk factors: a randomized controlled trial.
Human
92 men and women with abdominal obesity and relatively low HDL-cholesterol concentrationsSFAs from butter constituted 12.4-12.6% of total calories in the diet.Comparison of the impact of SFAs from cheese and butter on cardiometabolic risk factors: a randomized controlled trial.
Human
92 men and women with abdominal obesity and relatively low HDL-cholesterol concentrationsSFAs from butter constituted 12.4-12.6% of total calories in the diet.Comparison of the impact of SFAs from cheese and butter on cardiometabolic risk factors: a randomized controlled trial.
Human
individuals with high baseline LDL-cholesterol concentrationsSFAs from butter constituted 12.4-12.6% of total calories in the diet.Comparison of the impact of SFAs from cheese and butter on cardiometabolic risk factors: a randomized controlled trial.
Human
92 men and women with abdominal obesity and relatively low HDL-cholesterol concentrationsSFAs from butter constituted 12.4-12.6% of total calories in the diet.Comparison of the impact of SFAs from cheese and butter on cardiometabolic risk factors: a randomized controlled trial.
Human
92 men and women with abdominal obesity and relatively low HDL-cholesterol concentrationsSFAs from butter constituted 12.4-12.6% of total calories in the diet.Comparison of the impact of SFAs from cheese and butter on cardiometabolic risk factors: a randomized controlled trial.
Human
92 men and women with abdominal obesity and relatively low HDL-cholesterol concentrationsSFAs from butter constituted 12.4-12.6% of total calories in the diet.Comparison of the impact of SFAs from cheese and butter on cardiometabolic risk factors: a randomized controlled trial.
Human
92 men and women with abdominal obesity and relatively low HDL-cholesterol concentrationsSFAs from butter constituted 12.4-12.6% of total calories in the diet.Comparison of the impact of SFAs from cheese and butter on cardiometabolic risk factors: a randomized controlled trial.
Human
children affected with familial hypercholesterolaemia (FH)14-27 g/day of either rapeseed oil or sunflower oil.Effect of a low-fat diet enriched either with rapeseed oil or sunflower oil on plasma lipoproteins in children and adolescents with familial hypercholesterolaemia. Results of a pilot study.
Human
children affected with familial hypercholesterolaemia (FH)14-27 g/day of either rapeseed oil or sunflower oil.Effect of a low-fat diet enriched either with rapeseed oil or sunflower oil on plasma lipoproteins in children and adolescents with familial hypercholesterolaemia. Results of a pilot study.
Human
children affected with familial hypercholesterolaemia (FH)14-27 g/day of either rapeseed oil or sunflower oil.Effect of a low-fat diet enriched either with rapeseed oil or sunflower oil on plasma lipoproteins in children and adolescents with familial hypercholesterolaemia. Results of a pilot study.
Human
children affected with familial hypercholesterolaemia (FH)14-27 g/day of either rapeseed oil or sunflower oil.Effect of a low-fat diet enriched either with rapeseed oil or sunflower oil on plasma lipoproteins in children and adolescents with familial hypercholesterolaemia. Results of a pilot study.
Human
children affected with familial hypercholesterolaemia (FH)14-27 g/day of either rapeseed oil or sunflower oil.Effect of a low-fat diet enriched either with rapeseed oil or sunflower oil on plasma lipoproteins in children and adolescents with familial hypercholesterolaemia. Results of a pilot study.
Human
children affected with familial hypercholesterolaemia (FH)14-27 g/day of either rapeseed oil or sunflower oil.Effect of a low-fat diet enriched either with rapeseed oil or sunflower oil on plasma lipoproteins in children and adolescents with familial hypercholesterolaemia. Results of a pilot study.
Human
children affected with familial hypercholesterolaemia (FH)14-27 g/day of either rapeseed oil or sunflower oil.Effect of a low-fat diet enriched either with rapeseed oil or sunflower oil on plasma lipoproteins in children and adolescents with familial hypercholesterolaemia. Results of a pilot study.
Animal
Birds1% DHA-rich Aurantiochytrium (1.2 g DHA/kg diet) in Exp. 1; 0.33-0.66% DHA-rich oil (1.5-3.0 g DHA/kg diet) in Exp. 2Supranutrition of microalgal docosahexaenoic acid and calcidiol improved growth performance, tissue lipid profiles, and tibia characteristics of broiler chickens.
Animal
Birds1% DHA-rich Aurantiochytrium (1.2 g DHA/kg diet) in Exp. 1; 0.33-0.66% DHA-rich oil (1.5-3.0 g DHA/kg diet) in Exp. 2Supranutrition of microalgal docosahexaenoic acid and calcidiol improved growth performance, tissue lipid profiles, and tibia characteristics of broiler chickens.
Animal
Birds1% DHA-rich Aurantiochytrium (1.2 g DHA/kg diet) in Exp. 1; 0.33-0.66% DHA-rich oil (1.5-3.0 g DHA/kg diet) in Exp. 2Supranutrition of microalgal docosahexaenoic acid and calcidiol improved growth performance, tissue lipid profiles, and tibia characteristics of broiler chickens.
Animal
Birds1% DHA-rich Aurantiochytrium (1.2 g DHA/kg diet) in Exp. 1; 0.33-0.66% DHA-rich oil (1.5-3.0 g DHA/kg diet) in Exp. 2Supranutrition of microalgal docosahexaenoic acid and calcidiol improved growth performance, tissue lipid profiles, and tibia characteristics of broiler chickens.
Animal
Birds1% DHA-rich Aurantiochytrium (1.2 g DHA/kg diet) in Exp. 1; 0.33-0.66% DHA-rich oil (1.5-3.0 g DHA/kg diet) in Exp. 2Supranutrition of microalgal docosahexaenoic acid and calcidiol improved growth performance, tissue lipid profiles, and tibia characteristics of broiler chickens.
Animal
Birds1% DHA-rich Aurantiochytrium (1.2 g DHA/kg diet) in Exp. 1; 0.33-0.66% DHA-rich oil (1.5-3.0 g DHA/kg diet) in Exp. 2Supranutrition of microalgal docosahexaenoic acid and calcidiol improved growth performance, tissue lipid profiles, and tibia characteristics of broiler chickens.
Animal
Birds1% DHA-rich Aurantiochytrium (1.2 g DHA/kg diet) in Exp. 1; 0.33-0.66% DHA-rich oil (1.5-3.0 g DHA/kg diet) in Exp. 2Supranutrition of microalgal docosahexaenoic acid and calcidiol improved growth performance, tissue lipid profiles, and tibia characteristics of broiler chickens.
Animal
Birds1% DHA-rich Aurantiochytrium (1.2 g DHA/kg diet) in Exp. 1; 0.33-0.66% DHA-rich oil (1.5-3.0 g DHA/kg diet) in Exp. 2Supranutrition of microalgal docosahexaenoic acid and calcidiol improved growth performance, tissue lipid profiles, and tibia characteristics of broiler chickens.
Human
women with extensive mammographic densitiesNot specifiedLong-term effects of participation in a randomized trial of a low-fat, high-carbohydrate diet.
Human
women with extensive mammographic densitiesNot specifiedLong-term effects of participation in a randomized trial of a low-fat, high-carbohydrate diet.
Human
1/2 portion of Avocado per day.Effects of an Avocado-based Mediterranean Diet on Serum Lipids for Secondary Prevention after Ischemic Stroke Trial (ADD-SPISE): Study protocol.
Human
patients with the AA genotypeNot specifiedInteraction of the variant in the adiponectin gene rs3774261 with serum lipid profile and adiponectin levels after 9 months with a high monounsaturated fat hypocaloric diet with Mediterranean pattern.
Human
patients with the AA genotypeNot specifiedInteraction of the variant in the adiponectin gene rs3774261 with serum lipid profile and adiponectin levels after 9 months with a high monounsaturated fat hypocaloric diet with Mediterranean pattern.
Human
G allele carriers of ADIPOQ gene variant (rs3774261)Not specifiedInteraction of the variant in the adiponectin gene rs3774261 with serum lipid profile and adiponectin levels after 9 months with a high monounsaturated fat hypocaloric diet with Mediterranean pattern.
Human
G allele carriers of ADIPOQ gene variant (rs3774261)Not specifiedInteraction of the variant in the adiponectin gene rs3774261 with serum lipid profile and adiponectin levels after 9 months with a high monounsaturated fat hypocaloric diet with Mediterranean pattern.
Human
individuals with the CETP rs3764261 CC genotypeNot specifiedCETP genotype and changes in lipid levels in response to weight-loss diet intervention in the POUNDS LOST and DIRECT randomized trials.
Human
participants with the CETP rs3764261 CC genotypeNot specifiedCETP genotype and changes in lipid levels in response to weight-loss diet intervention in the POUNDS LOST and DIRECT randomized trials.
Human
participants carrying other genotypesNot specifiedCETP genotype and changes in lipid levels in response to weight-loss diet intervention in the POUNDS LOST and DIRECT randomized trials.
Human
obese individualsNot specified (dietary intake assessed via FFQ, LCD score based on deciles of intake).Low-carbohydrate diet score is associated with improved blood pressure and cardio-metabolic risk factors among obese adults.
Human
middle-to-older aged adults1.0g·kg BM-1·day-1 of protein from either animal (whey) or plant (pea) sources.Resistance training increases myofibrillar protein synthesis in middle-to-older aged adults consuming a typical diet with no influence of protein source: a randomized controlled trial.
Human
overweight or obese patients with PCOSNot specified (diet included 52%-55% carbohydrates, 16%-18% proteins, and 30% total fats, with low-fat dairy as part of the DASH diet).The effects of dietary approaches to stop hypertension diet on weight loss, anti-Müllerian hormone and metabolic profiles in women with polycystic ovary syndrome: A randomized clinical trial.
Human
adults with metabolic syndrome and LDL-C ≥ 160 mg/dLNot specified (medical food containing soy protein and plant sterols, plus a nutraceutical).Subjects with elevated LDL cholesterol and metabolic syndrome benefit from supplementation with soy protein, phytosterols, hops rho iso-alpha acids, and Acacia nilotica proanthocyanidins.
Human
adults with metabolic syndrome and LDL-C ≥ 160 mg/dLNot specified (medical food containing soy protein and plant sterols, plus a nutraceutical).Subjects with elevated LDL cholesterol and metabolic syndrome benefit from supplementation with soy protein, phytosterols, hops rho iso-alpha acids, and Acacia nilotica proanthocyanidins.
Human
6-month-old LP offspringPoor maternal nutrition programmes a pro-atherosclerotic phenotype in ApoE-/- mice.
Human
LP offspringPoor maternal nutrition programmes a pro-atherosclerotic phenotype in ApoE-/- mice.
Human
Diet2 participants (n = 29)Saturated fat intake reduced to <10% of energy intake (Diet1); Mediterranean Portfolio Diet with cholesterol-lowering foods (Diet2).Randomized parallel-group pilot trial (Best foods for your heart) comparing the effects of a Mediterranean Portfolio diet with a low saturated fat diet on HIV dyslipidemia.
Human
Saturated fat intake reduced to <10% of energy intake (Diet1); Mediterranean Portfolio Diet with cholesterol-lowering foods (Diet2).Randomized parallel-group pilot trial (Best foods for your heart) comparing the effects of a Mediterranean Portfolio diet with a low saturated fat diet on HIV dyslipidemia.
Human
people living with HIVSaturated fat intake reduced to <10% of energy intake (Diet1); Mediterranean Portfolio Diet with cholesterol-lowering foods (Diet2).Randomized parallel-group pilot trial (Best foods for your heart) comparing the effects of a Mediterranean Portfolio diet with a low saturated fat diet on HIV dyslipidemia.
Human
patients with coronary heart diseasesNot specified for the diet; medications: athenolol (50 mg daily) and hypotiazide (25 mg daily).[The treatment of coronary heart disease by beta-adrenoblockers or tiazide diuretics preparation in combination with vegetarian diet].
Human
patients with coronary heart diseasesNot specified for the diet; medications: athenolol (50 mg daily) and hypotiazide (25 mg daily).[The treatment of coronary heart disease by beta-adrenoblockers or tiazide diuretics preparation in combination with vegetarian diet].
Human
patients with coronary heart diseasesNot specified for the diet; medications: athenolol (50 mg daily) and hypotiazide (25 mg daily).[The treatment of coronary heart disease by beta-adrenoblockers or tiazide diuretics preparation in combination with vegetarian diet].
Human
patients with coronary heart diseasesNot specified for the diet; medications: athenolol (50 mg daily) and hypotiazide (25 mg daily).[The treatment of coronary heart disease by beta-adrenoblockers or tiazide diuretics preparation in combination with vegetarian diet].
Human
patients with coronary heart diseasesNot specified for the diet; medications: athenolol (50 mg daily) and hypotiazide (25 mg daily).[The treatment of coronary heart disease by beta-adrenoblockers or tiazide diuretics preparation in combination with vegetarian diet].
Human
patients with coronary heart diseasesNot specified for the diet; medications: athenolol (50 mg daily) and hypotiazide (25 mg daily).[The treatment of coronary heart disease by beta-adrenoblockers or tiazide diuretics preparation in combination with vegetarian diet].
Animal
ratsSoybean amplifies the hypohomocysteinemic effect of betaine and improves its hypercholesterolemic effect.
Animal
ratsSoybean amplifies the hypohomocysteinemic effect of betaine and improves its hypercholesterolemic effect.
Human
166 African AmericansTwo diets—37% total fat (16% SFA) vs. 25% total fat (6% SFA).Reducing saturated fat intake lowers LDL-C but increases Lp(a) levels in African Americans: the GET-READI feeding trial.
Human
overweight and obese women selected according to indexes of insulin resistance or dyslipidemiaNot specified (all foods and beverages were provided).A randomized controlled-feeding trial based on the Dietary Guidelines for Americans on cardiometabolic health indexes.
Human
overweight and obese women selected according to indexes of insulin resistance or dyslipidemiaNot specified (all foods and beverages were provided).A randomized controlled-feeding trial based on the Dietary Guidelines for Americans on cardiometabolic health indexes.
Human
overweight and obese women selected according to indexes of insulin resistance or dyslipidemiaNot specified (all foods and beverages were provided).A randomized controlled-feeding trial based on the Dietary Guidelines for Americans on cardiometabolic health indexes.
Human
overweight and obese women selected according to indexes of insulin resistance or dyslipidemiaNot specified (all foods and beverages were provided).A randomized controlled-feeding trial based on the Dietary Guidelines for Americans on cardiometabolic health indexes.
Human
overweight male patients with drug addictionNot specifiedEffects of an 8-week Baduanjin intervention combined with low-carbohydrates diet among overweight people who struggle with drug addiction.
Human
NAFLD patientsNot specifiedHypocaloric high-protein diet improves clinical and biochemical markers in patients with nonalcoholic fatty liver disease (NAFLD).
Human
NAFLD patientsNot specifiedHypocaloric high-protein diet improves clinical and biochemical markers in patients with nonalcoholic fatty liver disease (NAFLD).
Human
NAFLD patientsNot specifiedHypocaloric high-protein diet improves clinical and biochemical markers in patients with nonalcoholic fatty liver disease (NAFLD).
Human
NAFLD patientsNot specifiedHypocaloric high-protein diet improves clinical and biochemical markers in patients with nonalcoholic fatty liver disease (NAFLD).
Human
patients with CHD in VGNot specified (dietary intervention only).[Leveling the hyperlipidemic effect of beta-adrenoblockers by means of antiatherogenic vegetarian diet].
Human
patients with CHD in VGNot specified (dietary intervention only).[Leveling the hyperlipidemic effect of beta-adrenoblockers by means of antiatherogenic vegetarian diet].
Human
patients with CHD in VGNot specified (dietary intervention only).[Leveling the hyperlipidemic effect of beta-adrenoblockers by means of antiatherogenic vegetarian diet].
Human
patients with CHD in CGNot specified (dietary intervention only).[Leveling the hyperlipidemic effect of beta-adrenoblockers by means of antiatherogenic vegetarian diet].
Human
patients with CHD in CGNot specified (dietary intervention only).[Leveling the hyperlipidemic effect of beta-adrenoblockers by means of antiatherogenic vegetarian diet].
Human
patients with CHD in CGNot specified (dietary intervention only).[Leveling the hyperlipidemic effect of beta-adrenoblockers by means of antiatherogenic vegetarian diet].
Human
advanced CKD adult patientsNot specifiedCompliance, Adherence and Concordance Differently Predict the Improvement of Uremic and Microbial Toxins in Chronic Kidney Disease on Low Protein Diet.
Human
non-dialysis CKD patients0.6g/kg/day of protein.Effects of Low-Protein Diet on lipid and anthropometric profiles of patients with chronic kidney disease on conservative management.
Human
non-dialysis CKD patients0.6g/kg/day of protein.Effects of Low-Protein Diet on lipid and anthropometric profiles of patients with chronic kidney disease on conservative management.
Human
nondialysis chronic kidney disease (CKD) patients (stage 3-4) who adhered to the diet0.6 g/kg/day (prescribed), actual intake 0.7 ± 0.2 g/kg/dayDoes Low-Protein Diet Influence the Uremic Toxin Serum Levels From the Gut Microbiota in Nondialysis Chronic Kidney Disease Patients?
Human
nondialysis chronic kidney disease (CKD) patients (stage 3-4) who adhered to the diet0.6 g/kg/day (prescribed), actual intake 0.7 ± 0.2 g/kg/dayDoes Low-Protein Diet Influence the Uremic Toxin Serum Levels From the Gut Microbiota in Nondialysis Chronic Kidney Disease Patients?
Human
sixty patients affected by advanced CKDNot specifiedProbiotics-Supplemented Low-Protein Diet for Microbiota Modulation in Patients with Advanced Chronic Kidney Disease (ProLowCKD): Results from a Placebo-Controlled Randomized Trial.
Human
patients with hyperlipoproteinemia type IIa"Prudent" diet (20% protein, 35% carbohydrates, 45% fats, PS-factor ~2.2) for 7-10 days; clofibrate (500 mg twice daily) for 14 days.[Treatment of hyperlipoproteinemia type IIa with a "prudent" diet and clofibrate (author's transl)].
Human
patients with hyperlipoproteinemia type IIa"Prudent" diet (20% protein, 35% carbohydrates, 45% fats, PS-factor ~2.2) for 7-10 days; clofibrate (500 mg twice daily) for 14 days.[Treatment of hyperlipoproteinemia type IIa with a "prudent" diet and clofibrate (author's transl)].
Human
Women who completed treatment for breast cancerNot specified (menu and recipe-defined dietary patterns).Effect of dietary patterns differing in carbohydrate and fat content on blood lipid and glucose profiles based on weight-loss success of breast-cancer survivors.
Human
Women who completed treatment for breast cancerNot specified (menu and recipe-defined dietary patterns).Effect of dietary patterns differing in carbohydrate and fat content on blood lipid and glucose profiles based on weight-loss success of breast-cancer survivors.
Human
Women who completed treatment for breast cancerNot specified (menu and recipe-defined dietary patterns).Effect of dietary patterns differing in carbohydrate and fat content on blood lipid and glucose profiles based on weight-loss success of breast-cancer survivors.
Animal
six-week-old C57BL/6J miceBarley intake induces bile acid excretion by reduced expression of intestinal ASBT and NPC1L1 in C57BL/6J mice.
Animal
six-week-old C57BL/6J miceBarley intake induces bile acid excretion by reduced expression of intestinal ASBT and NPC1L1 in C57BL/6J mice.
Animal
six-week-old C57BL/6J miceBarley intake induces bile acid excretion by reduced expression of intestinal ASBT and NPC1L1 in C57BL/6J mice.
Human
patients with nonalcoholic fatty liver diseaseNot specifiedSoy diet for nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials.
Human
free-living men and women with hypercholesterolemia50 gm/day oat bran (LFLC + OB and OB groups) or 42.5 gm/day processed oat bran (POB group).Reduced serum cholesterol with dietary change using fat-modified and oat bran supplemented diets.
Human
free-living men and women with hypercholesterolemia50 gm/day oat bran (LFLC + OB and OB groups) or 42.5 gm/day processed oat bran (POB group).Reduced serum cholesterol with dietary change using fat-modified and oat bran supplemented diets.
Human
free-living men and women with hypercholesterolemia50 gm/day oat bran (LFLC + OB and OB groups) or 42.5 gm/day processed oat bran (POB group).Reduced serum cholesterol with dietary change using fat-modified and oat bran supplemented diets.
Human
free-living men and women with hypercholesterolemia50 gm/day oat bran (LFLC + OB and OB groups) or 42.5 gm/day processed oat bran (POB group).Reduced serum cholesterol with dietary change using fat-modified and oat bran supplemented diets.
Human
free-living men and women with hypercholesterolemia50 gm/day oat bran (LFLC + OB and OB groups) or 42.5 gm/day processed oat bran (POB group).Reduced serum cholesterol with dietary change using fat-modified and oat bran supplemented diets.
Human
free-living men and women with hypercholesterolemia50 gm/day oat bran (LFLC + OB and OB groups) or 42.5 gm/day processed oat bran (POB group).Reduced serum cholesterol with dietary change using fat-modified and oat bran supplemented diets.
Human
free-living men and women with hypercholesterolemia50 gm/day oat bran (LFLC + OB and OB groups) or 42.5 gm/day processed oat bran (POB group).Reduced serum cholesterol with dietary change using fat-modified and oat bran supplemented diets.
Human
free-living men and women with hypercholesterolemia50 gm/day oat bran (LFLC + OB and OB groups) or 42.5 gm/day processed oat bran (POB group).Reduced serum cholesterol with dietary change using fat-modified and oat bran supplemented diets.
Human
free-living men and women with hypercholesterolemia50 gm/day oat bran (LFLC + OB and OB groups) or 42.5 gm/day processed oat bran (POB group).Reduced serum cholesterol with dietary change using fat-modified and oat bran supplemented diets.
Human
free-living men and women with hypercholesterolemia50 gm/day oat bran (LFLC + OB and OB groups) or 42.5 gm/day processed oat bran (POB group).Reduced serum cholesterol with dietary change using fat-modified and oat bran supplemented diets.
Human
free-living men and women with hypercholesterolemia50 gm/day oat bran (LFLC + OB and OB groups) or 42.5 gm/day processed oat bran (POB group).Reduced serum cholesterol with dietary change using fat-modified and oat bran supplemented diets.
Human
free-living men and women with hypercholesterolemia50 gm/day oat bran (LFLC + OB and OB groups) or 42.5 gm/day processed oat bran (POB group).Reduced serum cholesterol with dietary change using fat-modified and oat bran supplemented diets.
HumanAnimal
Male C57 BL6 miceHigh-fat (30% lard, 0.2% cholesterol, ~57% calories) and sucrose-rich (20%) chow, plus high-sugar solution (23.1 g/L D-fructose, 18.9 g/L D-glucose)Western diet-induced mouse model of non-alcoholic fatty liver disease associated with metabolic outcomes: Features of gut microbiome-liver-adipose tissue axis.
Human
healthy moderately hypercholesterolemic humansMilk fat provided 38% of energy intake in the three dairy-based diets.Effect of milk fat on LDL cholesterol and other cardiovascular risk markers in healthy humans: the INNOVALAIT project.
Human
healthy moderately hypercholesterolemic humansMilk fat provided 38% of energy intake in the three dairy-based diets.Effect of milk fat on LDL cholesterol and other cardiovascular risk markers in healthy humans: the INNOVALAIT project.
Human
kidney transplant recipients in the DIET groupNot specified (diet-based intervention)Effects of a diet rich in N-3 polyunsaturated fatty acids on systemic inflammation in renal transplant recipients.
Animal
premature male rats (CFG1)L-Carnitine effect on induced hyperlipidemia on premature rats: fertility profile.
Human
subjects with obesity or overweight and at least one of type 2 diabetes, ischaemic heart disease, hypertension or hypercholesterolaemiaNon-energy-restricted WFPB diet with vitamin B12 supplementation; no specific dosage mentioned.The BROAD study: A randomised controlled trial using a whole food plant-based diet in the community for obesity, ischaemic heart disease or diabetes.
Human
subjects with obesity or overweight and at least one of type 2 diabetes, ischaemic heart disease, hypertension or hypercholesterolaemiaNon-energy-restricted WFPB diet with vitamin B12 supplementation; no specific dosage mentioned.The BROAD study: A randomised controlled trial using a whole food plant-based diet in the community for obesity, ischaemic heart disease or diabetes.
Human
WFPB diet groupNon-energy-restricted WFPB diet with vitamin B12 supplementation; no specific dosage mentioned.The BROAD study: A randomised controlled trial using a whole food plant-based diet in the community for obesity, ischaemic heart disease or diabetes.
Human
overweight and obese patients with type 2 diabetesNot specifiedImprovement of glycemic indices by a hypocaloric legume-based DASH diet in adults with type 2 diabetes: a randomized controlled trial.
Human
overweight and obese patients with type 2 diabetesNot specifiedImprovement of glycemic indices by a hypocaloric legume-based DASH diet in adults with type 2 diabetes: a randomized controlled trial.
Human
overweight and obese patients with type 2 diabetesNot specifiedImprovement of glycemic indices by a hypocaloric legume-based DASH diet in adults with type 2 diabetes: a randomized controlled trial.
Human
overweight and obese patients with type 2 diabetesNot specifiedImprovement of glycemic indices by a hypocaloric legume-based DASH diet in adults with type 2 diabetes: a randomized controlled trial.
Human
overweight or obese Chinese womenLC diet started at 20 g/d of carbohydrates, increasing by 10 g weekly; ER diet had 156-205 g/d of carbohydrates with a 35% energy reduction.Effects of a low-carbohydrate diet on weight loss and cardiometabolic profile in Chinese women: a randomised controlled feeding trial.
Human
overweight or obese Chinese womenLC diet started at 20 g/d of carbohydrates, increasing by 10 g weekly; ER diet had 156-205 g/d of carbohydrates with a 35% energy reduction.Effects of a low-carbohydrate diet on weight loss and cardiometabolic profile in Chinese women: a randomised controlled feeding trial.
Human
a 47-year-old woman with HER2-positive breast cancerNot specified (whole-food, plant-based diet with or without 16-hour overnight fasting).Plant-Based Diet and IGF-1 Modulation on HER2-Positive Breast Cancer: A Lifestyle Medicine Nutrition Approach in Oncology.
Human
moderately overweight, middle-aged individualsControl diet (<10 mg lycopene/week), lycopene-rich diet (224-350 mg lycopene/week), lycopene supplement (70 mg lycopene/week)Lycopene intervention reduces inflammation and improves HDL functionality in moderately overweight middle-aged individuals.
Human
moderately overweight, middle-aged individualsControl diet (<10 mg lycopene/week), lycopene-rich diet (224-350 mg lycopene/week), lycopene supplement (70 mg lycopene/week)Lycopene intervention reduces inflammation and improves HDL functionality in moderately overweight middle-aged individuals.
Human
patients with severe hypertriglyceridemiaNot specified (formula diet composition details not provided).Successful treatment of severe hypertriglyceridemia with a formula diet rich in omega-3 fatty acids and medium-chain triglycerides.
Human
prostate cancer survivors receiving androgen deprivation therapyNot specifiedThe effect of dietary interventions or patterns on the cardiometabolic health of individuals treated with androgen deprivation therapy for prostate cancer: A systematic review.
Animal
WT miceImpaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study.
Animal
CF miceImpaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study.
Animal
WT miceImpaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study.
Human
obese women30 g/day of whey protein powder.Whey protein supplementation reducing fasting levels of anandamide and 2-AG without weight loss in pre-menopausal women with obesity on a weight-loss diet.
Animal
male Wistar ratsThe mechanism of dietary cholesterol effects on lipids metabolism in rats.
Animal
male Wistar ratsThe mechanism of dietary cholesterol effects on lipids metabolism in rats.
Animal
male Wistar ratsThe mechanism of dietary cholesterol effects on lipids metabolism in rats.
Human
postmenopausal womenNot specified (butter was part of a diet with 38% fat, 20% saturated fat).Impact of the consumption of a rich diet in butter and it replacement for a rich diet in extra virgin olive oil on anthropometric, metabolic and lipid profile in postmenopausal women.
Animal
ratsBiofortified kale enriched with 5,7-diiodo-8-quinolinol (exact dosage not specified)Comparative Analysis of Iodine Levels, Biochemical Responses, and Thyroid Gene Expression in Rats Fed Diets with Kale Biofortified with 5,7-Diiodo-8-Quinolinol.
Human
overweight and obese women with BMI >2550 g of almonds daily.The effect of almonds on anthropometric measurements and lipid profile in overweight and obese females in a weight reduction program: A randomized controlled clinical trial.
Human
overweight and obese women with BMI >2550 g of almonds daily.The effect of almonds on anthropometric measurements and lipid profile in overweight and obese females in a weight reduction program: A randomized controlled clinical trial.
Human
overweight and obese women with BMI >2550 g of almonds daily.The effect of almonds on anthropometric measurements and lipid profile in overweight and obese females in a weight reduction program: A randomized controlled clinical trial.
Human
overweight and obese women with BMI >2550 g of almonds daily.The effect of almonds on anthropometric measurements and lipid profile in overweight and obese females in a weight reduction program: A randomized controlled clinical trial.
Human
overweight and obese womenDietary plan composition: 55-60% carbohydrates, 15-20% protein, 25-30% fat.Which is the best diet to reduce cardiometabolic risk: dietary counseling or home-delivered diet?
Human
overweight and obese womenDietary plan composition: 55-60% carbohydrates, 15-20% protein, 25-30% fat.Which is the best diet to reduce cardiometabolic risk: dietary counseling or home-delivered diet?
Human
obese individuals500 mL/day of 100% orange juice.Orange juice allied to a reduced-calorie diet results in weight loss and ameliorates obesity-related biomarkers: A randomized controlled trial.
Human
obese individuals500 mL/day of 100% orange juice.Orange juice allied to a reduced-calorie diet results in weight loss and ameliorates obesity-related biomarkers: A randomized controlled trial.
Human
Multi-ethnic Asian adults with body mass index ≥ 27.5 kg/m2Net carbohydrate intake limited to ≤50 g per day for the HKD group.Development and Pragmatic Randomized Controlled Trial of Healthy Ketogenic Diet Versus Energy-Restricted Diet on Weight Loss in Adults with Obesity.
Human
Multi-ethnic Asian adults with body mass index ≥ 27.5 kg/m2Net carbohydrate intake limited to ≤50 g per day for the HKD group.Development and Pragmatic Randomized Controlled Trial of Healthy Ketogenic Diet Versus Energy-Restricted Diet on Weight Loss in Adults with Obesity.
Human
overweight and obese women with PCOS12 × 10^9 CFU/day of Lactobacillus rhamnosus.A low glycemic index, energy-restricted diet but not Lactobacillus rhamnosus supplementation changes fecal short-chain fatty acid and serum lipid concentrations in women with overweight or obesity and polycystic ovary syndrome.
Human
overweight and obese women with PCOS12 × 10^9 CFU/day of Lactobacillus rhamnosus.A low glycemic index, energy-restricted diet but not Lactobacillus rhamnosus supplementation changes fecal short-chain fatty acid and serum lipid concentrations in women with overweight or obesity and polycystic ovary syndrome.
Human
obese volunteers with type 2 diabetes (DM2)High-protein low-fat diet (30% protein, 50% carbohydrates, 20% fat); low-protein high-fat diet (15% protein, 50% carbohydrates, 35% fat).A high-protein low-fat diet is more effective in improving blood pressure and triglycerides in calorie-restricted obese individuals with newly diagnosed type 2 diabetes.
Human
obese volunteers with type 2 diabetes (DM2)High-protein low-fat diet (30% protein, 50% carbohydrates, 20% fat); low-protein high-fat diet (15% protein, 50% carbohydrates, 35% fat).A high-protein low-fat diet is more effective in improving blood pressure and triglycerides in calorie-restricted obese individuals with newly diagnosed type 2 diabetes.
Human
obese volunteers with type 2 diabetes (DM2)High-protein low-fat diet (30% protein, 50% carbohydrates, 20% fat); low-protein high-fat diet (15% protein, 50% carbohydrates, 35% fat).A high-protein low-fat diet is more effective in improving blood pressure and triglycerides in calorie-restricted obese individuals with newly diagnosed type 2 diabetes.
Human
obese volunteers with type 2 diabetes (DM2)High-protein low-fat diet (30% protein, 50% carbohydrates, 20% fat); low-protein high-fat diet (15% protein, 50% carbohydrates, 35% fat).A high-protein low-fat diet is more effective in improving blood pressure and triglycerides in calorie-restricted obese individuals with newly diagnosed type 2 diabetes.
Human
individuals with overweight and obesityNot specifiedA lipidomic and metabolomic signature of a very low-carbohydrate high-fat diet and high-intensity interval training: an additional analysis of a randomized controlled clinical trial.
Human
children and adults with familial hypercholesterolaemiaNot specifiedDietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia.
Human
adultsNot specifiedThe Impact of Low Advanced Glycation End Products Diet on Metabolic Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Human
early-stage prostate cancer patientsVery-low-fat (10% fat) vegan diet supplemented with soy protein (specific dosage not detailed).A very-low-fat vegan diet increases intake of protective dietary factors and decreases intake of pathogenic dietary factors.
Animal
male ratsKetogenic diet improves and restores redox status and biochemical indices in monosodium glutamate-induced rat testicular toxicity.
Animal
male ratsKetogenic diet improves and restores redox status and biochemical indices in monosodium glutamate-induced rat testicular toxicity.
Human
116 treated or not primary hypertensive out-patientsNot specifiedImportance of weight loss and sodium restriction in the treatment of mild and moderate essential hypertension.
Human
patients affected by hyperlipidemia (group D)Not specifiedHypolipidic diet and phytosubstance supplement in hypercholesterolemia.
Human
patients affected by hyperlipidemia (group D)Not specifiedHypolipidic diet and phytosubstance supplement in hypercholesterolemia.
Human
patients affected by hyperlipidemia (group E)Not specifiedHypolipidic diet and phytosubstance supplement in hypercholesterolemia.
Human
patients affected by hyperlipidemia (group E)Not specifiedHypolipidic diet and phytosubstance supplement in hypercholesterolemia.
Human
healthy volunteers55 g fat per day, delivered via butter, dessert cream, and cookies.Differential impact of milk fatty acid profiles on cardiovascular risk biomarkers in healthy men and women.
Human
healthy volunteers55 g fat per day, delivered via butter, dessert cream, and cookies.Differential impact of milk fatty acid profiles on cardiovascular risk biomarkers in healthy men and women.
Human
healthy volunteers55 g fat per day, delivered via butter, dessert cream, and cookies.Differential impact of milk fatty acid profiles on cardiovascular risk biomarkers in healthy men and women.
Human
healthy volunteers55 g fat per day, delivered via butter, dessert cream, and cookies.Differential impact of milk fatty acid profiles on cardiovascular risk biomarkers in healthy men and women.
Human
healthy volunteers55 g fat per day, delivered via butter, dessert cream, and cookies.Differential impact of milk fatty acid profiles on cardiovascular risk biomarkers in healthy men and women.
Human
type 2 diabetes mellitus (T2DM) patientsA khorasan wheat-based replacement diet improves risk profile of patients with type 2 diabetes mellitus (T2DM): a randomized crossover trial.
Human
type 2 diabetes mellitus (T2DM) patientsA khorasan wheat-based replacement diet improves risk profile of patients with type 2 diabetes mellitus (T2DM): a randomized crossover trial.
Human
overweight and obese individuals aged 30 to 70 years42.5 g/d of almonds.Effects of Dark Chocolate and Almonds on Cardiovascular Risk Factors in Overweight and Obese Individuals: A Randomized Controlled-Feeding Trial.
Human
overweight and obese individuals aged 30 to 70 years42.5 g/d of almonds.Effects of Dark Chocolate and Almonds on Cardiovascular Risk Factors in Overweight and Obese Individuals: A Randomized Controlled-Feeding Trial.
Human
overweight and obese individuals aged 30 to 70 years42.5 g/d of almonds.Effects of Dark Chocolate and Almonds on Cardiovascular Risk Factors in Overweight and Obese Individuals: A Randomized Controlled-Feeding Trial.
Human
men and women with polygenic hypercholesterolemiaWalnuts replaced approximately 35% of the energy obtained from monounsaturated fat.Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women. A randomized crossover trial.
Human
men and women with polygenic hypercholesterolemiaWalnuts replaced approximately 35% of the energy obtained from monounsaturated fat.Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women. A randomized crossover trial.
Human
men and women with polygenic hypercholesterolemiaWalnuts replaced approximately 35% of the energy obtained from monounsaturated fat.Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women. A randomized crossover trial.
Human
men and women with polygenic hypercholesterolemiaWalnuts replaced approximately 35% of the energy obtained from monounsaturated fat.Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women. A randomized crossover trial.
Human
men and women with hypercholesterolemiaWalnuts replaced approximately 35% of the energy obtained from monounsaturated fat.Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women. A randomized crossover trial.
Human
men and women with hypercholesterolemiaWalnuts replaced approximately 35% of the energy obtained from monounsaturated fat.Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women. A randomized crossover trial.
Human
middle-aged overweight/obese subjects1.4 g cocoa extract (645.3 mg polyphenols) daily, incorporated into meals.Oxidised LDL levels decreases after the consumption of ready-to-eat meals supplemented with cocoa extract within a hypocaloric diet.
Animal
micePrebiotics modulate the microbiota-gut-brain axis and ameliorate anxiety and depression-like behavior in HFD-fed mice.
Animal
hypercholestremic adult male ratsHigh-fat diet induced alteration in lipid enzymes and inflammation in cardiac and brain tissues: Assessment of the effects of Atorvastatin-loaded nanoparticles.
Animal
male SD ratsEffect of high-fat diet on cholesterol metabolism in rats and its association with Na⁺/K⁺-ATPase/Src/pERK signaling pathway.
Animal
male SD ratsEffect of high-fat diet on cholesterol metabolism in rats and its association with Na⁺/K⁺-ATPase/Src/pERK signaling pathway.
Animal
male SD ratsEffect of high-fat diet on cholesterol metabolism in rats and its association with Na⁺/K⁺-ATPase/Src/pERK signaling pathway.
Animal
Sprague-Dawley ratsDietary Betaine Addition Promotes Hepatic Cholesterol Synthesis, Bile Acid Conversion, and Export in Rats.
Animal
Sprague-Dawley ratsDietary Betaine Addition Promotes Hepatic Cholesterol Synthesis, Bile Acid Conversion, and Export in Rats.
Animal
Sprague-Dawley ratsDietary Betaine Addition Promotes Hepatic Cholesterol Synthesis, Bile Acid Conversion, and Export in Rats.
Animal
Sprague-Dawley ratsDietary Betaine Addition Promotes Hepatic Cholesterol Synthesis, Bile Acid Conversion, and Export in Rats.
Animal
male C57BL/6 mice100 mg/kg/day administered via gavage.Resveratrol prevents gallstones in mice fed on a high fat diet via regulating PPAR-γ and SR-BI.
Animal
C57BL/6J mice100 mg/kg body weight/dayResveratrol ameliorates high‑fat diet‑induced insulin resistance via the DDIT4/mTOR pathway in skeletal muscle.
Animal
C57BL/6J mice100 mg/kg body weight/dayResveratrol ameliorates high‑fat diet‑induced insulin resistance via the DDIT4/mTOR pathway in skeletal muscle.
Animal
adult offspring ratsInfluencing factors, underlying mechanism and interactions affecting hypercholesterolemia in adult offspring with caffeine exposure during pregnancy.
Animal
adult offspring ratsInfluencing factors, underlying mechanism and interactions affecting hypercholesterolemia in adult offspring with caffeine exposure during pregnancy.
HumanAnimalMolecular
Sprague-Dawley rats150 mg/day (human study).High molecular weight poly-gamma-glutamic acid regulates lipid metabolism in rats fed a high-fat diet and humans.
HumanAnimalMolecular
Sprague-Dawley rats150 mg/day (human study).High molecular weight poly-gamma-glutamic acid regulates lipid metabolism in rats fed a high-fat diet and humans.
HumanAnimalMolecular
Sprague-Dawley rats150 mg/day (human study).High molecular weight poly-gamma-glutamic acid regulates lipid metabolism in rats fed a high-fat diet and humans.
HumanAnimalMolecular
Sprague-Dawley rats150 mg/day (human study).High molecular weight poly-gamma-glutamic acid regulates lipid metabolism in rats fed a high-fat diet and humans.
HumanAnimalMolecular
Sprague-Dawley rats150 mg/day (human study).High molecular weight poly-gamma-glutamic acid regulates lipid metabolism in rats fed a high-fat diet and humans.
HumanAnimalMolecular
Sprague-Dawley rats150 mg/day (human study).High molecular weight poly-gamma-glutamic acid regulates lipid metabolism in rats fed a high-fat diet and humans.
Human
overweight or obese adults aged 30-70 y (61% women) with LIPC A alleleHigh-fat diet (40% energy), low-fat diet (20% energy).Dietary Fat Intake Modifies the Effect of a Common Variant in the LIPC Gene on Changes in Serum Lipid Concentrations during a Long-Term Weight-Loss Intervention Trial.
Human
overweight or obese adults aged 30-70 y (61% women) with LIPC A alleleHigh-fat diet (40% energy), low-fat diet (20% energy).Dietary Fat Intake Modifies the Effect of a Common Variant in the LIPC Gene on Changes in Serum Lipid Concentrations during a Long-Term Weight-Loss Intervention Trial.
Human
overweight or obese adults aged 30-70 y (61% women) with LIPC A alleleHigh-fat diet (40% energy), low-fat diet (20% energy).Dietary Fat Intake Modifies the Effect of a Common Variant in the LIPC Gene on Changes in Serum Lipid Concentrations during a Long-Term Weight-Loss Intervention Trial.
Human
overweight or obese adults aged 30-70 y (61% women) with LIPC A alleleHigh-fat diet (40% energy), low-fat diet (20% energy).Dietary Fat Intake Modifies the Effect of a Common Variant in the LIPC Gene on Changes in Serum Lipid Concentrations during a Long-Term Weight-Loss Intervention Trial.
Human
overweight or obese adults aged 30-70 y (61% women) with LIPC A alleleHigh-fat diet (40% energy), low-fat diet (20% energy).Dietary Fat Intake Modifies the Effect of a Common Variant in the LIPC Gene on Changes in Serum Lipid Concentrations during a Long-Term Weight-Loss Intervention Trial.
Human
overweight or obese adults aged 30-70 y (61% women) with LIPC A alleleHigh-fat diet (40% energy), low-fat diet (20% energy).Dietary Fat Intake Modifies the Effect of a Common Variant in the LIPC Gene on Changes in Serum Lipid Concentrations during a Long-Term Weight-Loss Intervention Trial.
AnimalMolecular
Male C57BL/6J miceFolic acid supplementation during high-fat diet feeding restores AMPK activation via an AMP-LKB1-dependent mechanism.
Animal
Rats (Group 2)Effects of Honey on Postprandial Hyperlipidemia and Oxidative Stress in Wistar Rats: Role of HMG-CoA Reductase Inhibition and Antioxidant Effect.
Animal
Rats (Group 2)Effects of Honey on Postprandial Hyperlipidemia and Oxidative Stress in Wistar Rats: Role of HMG-CoA Reductase Inhibition and Antioxidant Effect.
Animal
Rats (Group 2)Effects of Honey on Postprandial Hyperlipidemia and Oxidative Stress in Wistar Rats: Role of HMG-CoA Reductase Inhibition and Antioxidant Effect.
Animal
Rats (Group 2)Effects of Honey on Postprandial Hyperlipidemia and Oxidative Stress in Wistar Rats: Role of HMG-CoA Reductase Inhibition and Antioxidant Effect.
Animal
miceNot specified (low-dose treatment mentioned but exact dosage not provided).Effects of α-Galactooligosaccharides from Chickpeas on High-Fat-Diet-Induced Metabolic Syndrome in Mice.
Animal
miceNot specified (low-dose treatment mentioned but exact dosage not provided).Effects of α-Galactooligosaccharides from Chickpeas on High-Fat-Diet-Induced Metabolic Syndrome in Mice.
Animal
miceNot specified (low-dose treatment mentioned but exact dosage not provided).Effects of α-Galactooligosaccharides from Chickpeas on High-Fat-Diet-Induced Metabolic Syndrome in Mice.
Human
12 nonobese healthy men with normal plasma lipid profileHigh-fat diet (37% energy from fat, 50% from carbohydrates) and low-fat diet (25% energy from fat, 62% from carbohydrates).Effect of short-term low- and high-fat diets on low-density lipoprotein particle size in normolipidemic subjects.
Human
12 nonobese healthy men with normal plasma lipid profileHigh-fat diet (37% energy from fat, 50% from carbohydrates) and low-fat diet (25% energy from fat, 62% from carbohydrates).Effect of short-term low- and high-fat diets on low-density lipoprotein particle size in normolipidemic subjects.
Human
12 nonobese healthy men with normal plasma lipid profileHigh-fat diet (37% energy from fat, 50% from carbohydrates) and low-fat diet (25% energy from fat, 62% from carbohydrates).Effect of short-term low- and high-fat diets on low-density lipoprotein particle size in normolipidemic subjects.
Animal
obese ratsNot specifiedEffect of caffeine-chitosan nanoparticles and α-lipoic acid on the cardiovascular changes induced in rat model of obesity.
Animal
obese ratsNot specifiedEffect of caffeine-chitosan nanoparticles and α-lipoic acid on the cardiovascular changes induced in rat model of obesity.
Animal
obese ratsNot specifiedEffect of caffeine-chitosan nanoparticles and α-lipoic acid on the cardiovascular changes induced in rat model of obesity.
Animal
obese ratsNot specifiedEffect of caffeine-chitosan nanoparticles and α-lipoic acid on the cardiovascular changes induced in rat model of obesity.
Animal
miceHistidine and carnosine alleviated hepatic steatosis in mice consumed high saturated fat diet.
Animal
Female C57BL/6 miceNot specifiedReduction of lauric acid content in virgin coconut oil improved plasma lipid profile in high-fat diet-induced hypercholesterolemic mice.
Animal
albino Wister ratsl-Carnitine-induced amelioration of HFD-induced hepatic dysfunction is accompanied by a reduction in hepatic TNF-α and TGF-β1.
Animal
Wistar rats200 mg/kg orally per dayEvaluation of antiobesity and cardioprotective effect of Gymnema sylvestre extract in murine model.
Animal
Wistar albino ratsAntihyperlipidemic Activity of Aloe succotrina in Rats: Possibly Mediated by Inhibition of HMG-CoA Reductase.
AnimalMolecular
miceIdentification of miR-185 as a regulator of de novo cholesterol biosynthesis and low density lipoprotein uptake.
HumanAnimalMolecular
high-fat/high-cholesterol-induced hyperlipidemic rat model7.5 g/rat/day of pellet diet containing King Oyster.In Vitro Antioxidant and In Vivo Hypolipidemic Effects of the King Oyster Culinary-Medicinal Mushroom, Pleurotus eryngii var. ferulae DDL01 (Agaricomycetes), in Rats with High-Fat Diet-Induced Fatty Liver and Hyperlipidemia.
HumanAnimalMolecular
high-fat/high-cholesterol-induced hyperlipidemic rat model7.5 g/rat/day of pellet diet containing King Oyster.In Vitro Antioxidant and In Vivo Hypolipidemic Effects of the King Oyster Culinary-Medicinal Mushroom, Pleurotus eryngii var. ferulae DDL01 (Agaricomycetes), in Rats with High-Fat Diet-Induced Fatty Liver and Hyperlipidemia.
HumanAnimalMolecular
high-fat/high-cholesterol-induced hyperlipidemic rat model7.5 g/rat/day of pellet diet containing King Oyster.In Vitro Antioxidant and In Vivo Hypolipidemic Effects of the King Oyster Culinary-Medicinal Mushroom, Pleurotus eryngii var. ferulae DDL01 (Agaricomycetes), in Rats with High-Fat Diet-Induced Fatty Liver and Hyperlipidemia.
Human
obese patients with CC genotypeDiet HP: 33% carbohydrates (86.1 g/day), 33% fat (39.0 g/day), 34% protein (88.6 g/day). Diet S: 1093 cal/day, 53% carbohydrates (144.3 g/day), 27% fat (32.6 g/day), 20% protein (55.6 g/day).Adiponectin gene variant rs266729 interacts with different macronutrient distributions of two different hypocaloric diets during nine months.
Human
obese patients with CC genotypeDiet HP: 33% carbohydrates (86.1 g/day), 33% fat (39.0 g/day), 34% protein (88.6 g/day). Diet S: 1093 cal/day, 53% carbohydrates (144.3 g/day), 27% fat (32.6 g/day), 20% protein (55.6 g/day).Adiponectin gene variant rs266729 interacts with different macronutrient distributions of two different hypocaloric diets during nine months.
Human
obese patients with CC genotypeDiet HP: 33% carbohydrates (86.1 g/day), 33% fat (39.0 g/day), 34% protein (88.6 g/day). Diet S: 1093 cal/day, 53% carbohydrates (144.3 g/day), 27% fat (32.6 g/day), 20% protein (55.6 g/day).Adiponectin gene variant rs266729 interacts with different macronutrient distributions of two different hypocaloric diets during nine months.
Human
obese patients with CC genotypeDiet HP: 33% carbohydrates (86.1 g/day), 33% fat (39.0 g/day), 34% protein (88.6 g/day). Diet S: 1093 cal/day, 53% carbohydrates (144.3 g/day), 27% fat (32.6 g/day), 20% protein (55.6 g/day).Adiponectin gene variant rs266729 interacts with different macronutrient distributions of two different hypocaloric diets during nine months.
Animal
HS/CT rats34.3% protein in diet.Long-term high-protein diet intake reverts weight gain and attenuates metabolic dysfunction on high-sucrose-fed adult rats.
Animal
HS/HP rats34.3% protein in diet.Long-term high-protein diet intake reverts weight gain and attenuates metabolic dysfunction on high-sucrose-fed adult rats.
Human
variably controlled NIDDM subjectsNot specified (diets contained 35% fat as monounsaturated fat).Diets high and low in glycemic index versus high monounsaturated fat diets: effects on glucose and lipid metabolism in NIDDM.
Human
variably controlled NIDDM subjectsNot specified (diets contained 35% fat as monounsaturated fat).Diets high and low in glycemic index versus high monounsaturated fat diets: effects on glucose and lipid metabolism in NIDDM.
Human
variably controlled NIDDM subjectsNot specified (diets contained 35% fat as monounsaturated fat).Diets high and low in glycemic index versus high monounsaturated fat diets: effects on glucose and lipid metabolism in NIDDM.
Human
first-degree relatives of Type-2 DM patients55% of energy from carbohydrates, 30% from fat, 15% from protein (CHO diet).Comparison of the effects of a monounsaturated fat diet and a high carbohydrate diet on cardiovascular risk factors in first degree relatives to type-2 diabetic subjects.
Human
first-degree relatives of Type-2 DM patients55% of energy from carbohydrates, 30% from fat, 15% from protein (CHO diet).Comparison of the effects of a monounsaturated fat diet and a high carbohydrate diet on cardiovascular risk factors in first degree relatives to type-2 diabetic subjects.
Human
first-degree relatives of Type-2 DM patients55% of energy from carbohydrates, 30% from fat, 15% from protein (CHO diet).Comparison of the effects of a monounsaturated fat diet and a high carbohydrate diet on cardiovascular risk factors in first degree relatives to type-2 diabetic subjects.
Human
first-degree relatives of Type-2 DM patients55% of energy from carbohydrates, 30% from fat, 15% from protein (CHO diet).Comparison of the effects of a monounsaturated fat diet and a high carbohydrate diet on cardiovascular risk factors in first degree relatives to type-2 diabetic subjects.
Human
first-degree relatives of Type-2 DM patients55% of energy from carbohydrates, 30% from fat, 15% from protein (CHO diet).Comparison of the effects of a monounsaturated fat diet and a high carbohydrate diet on cardiovascular risk factors in first degree relatives to type-2 diabetic subjects.
Human
overweight and obese participants2.5 hours of walking per week.Moderate Walking Enhances the Effects of an Energy-Restricted Diet on Fat Mass Loss and Serum Insulin in Overweight and Obese Adults in a 12-Week Randomized Controlled Trial.
Human
overweight and obese participants2.5 hours of walking per week.Moderate Walking Enhances the Effects of an Energy-Restricted Diet on Fat Mass Loss and Serum Insulin in Overweight and Obese Adults in a 12-Week Randomized Controlled Trial.
Human
overweight and obese participants2.5 hours of walking per week.Moderate Walking Enhances the Effects of an Energy-Restricted Diet on Fat Mass Loss and Serum Insulin in Overweight and Obese Adults in a 12-Week Randomized Controlled Trial.
Human
overweight and obese participants2.5 hours of walking per week.Moderate Walking Enhances the Effects of an Energy-Restricted Diet on Fat Mass Loss and Serum Insulin in Overweight and Obese Adults in a 12-Week Randomized Controlled Trial.
Human
outpatients with non-alcoholic steatohepatitisNot specified for alanine; overall diet composition was 1,651.34 ± 263.25 kcal, 25% proteins.Effects of Dietary Intervention on Gut Microbiota and Metabolic-Nutritional Profile of Outpatients with Non-Alcoholic Steatohepatitis: a Randomized Clinical Trial.
Human
healthy subjectsNot specified (used for cooking and as table margarine).Similar serum lipoprotein cholesterol concentrations in healthy subjects on diets enriched with rapeseed and with sunflower oil.
Human
healthy subjectsNot specified (used for cooking and as table margarine).Similar serum lipoprotein cholesterol concentrations in healthy subjects on diets enriched with rapeseed and with sunflower oil.
Human
healthy subjectsNot specified (used for cooking and as table margarine).Similar serum lipoprotein cholesterol concentrations in healthy subjects on diets enriched with rapeseed and with sunflower oil.
Human
healthy subjectsNot specified (used for cooking and as table margarine).Similar serum lipoprotein cholesterol concentrations in healthy subjects on diets enriched with rapeseed and with sunflower oil.
Human
healthy subjectsNot specified (used for cooking and as table margarine).Similar serum lipoprotein cholesterol concentrations in healthy subjects on diets enriched with rapeseed and with sunflower oil.
Human
healthy subjectsNot specified (used for cooking and as table margarine).Similar serum lipoprotein cholesterol concentrations in healthy subjects on diets enriched with rapeseed and with sunflower oil.
Human
sixty-three men58% of energy as carbohydrates (ad libitum consumption)Variations in body composition and plasma lipids in response to a high-carbohydrate diet.
Human
high-CHO group58% of energy as carbohydrates (ad libitum consumption)Variations in body composition and plasma lipids in response to a high-carbohydrate diet.
Human
sixty-three men58% of energy as carbohydrates (ad libitum consumption)Variations in body composition and plasma lipids in response to a high-carbohydrate diet.
Human
sixty-three men58% of energy as carbohydrates (ad libitum consumption)Variations in body composition and plasma lipids in response to a high-carbohydrate diet.
Human
high-MUFA group58% of energy as carbohydrates (ad libitum consumption)Variations in body composition and plasma lipids in response to a high-carbohydrate diet.
Human
sixty-three men58% of energy as carbohydrates (ad libitum consumption)Variations in body composition and plasma lipids in response to a high-carbohydrate diet.
Human
sixty-three men58% of energy as carbohydrates (ad libitum consumption)Variations in body composition and plasma lipids in response to a high-carbohydrate diet.
Human
overweight omnivores with a low-to-moderate cardiovascular risk profileNot specified (low-calorie diets).Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet).
Human
overweight omnivores with a low-to-moderate cardiovascular risk profileNot specified (low-calorie diets).Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet).
Animal
laying hensBasal diet contained 100 mg/kg VE.Effects of supplementation of different selenium sources on lipid profile, selenium, and vitamin E concentration of yolk.
Human
children with obesity aged 8-11 yearsAID included fruits, vegetables, fish, lean meats, omega-3 sources, nuts, legumes, and probiotic products, with elimination of inflammatory foods. Ginger dosage was 1000 mg/day.Combination of the effect of ginger and anti-inflammatory diet on children with obesity with nonalcoholic fatty liver disease: A randomized clinical trial.
Human
children with obesity aged 8-11 yearsAID included fruits, vegetables, fish, lean meats, omega-3 sources, nuts, legumes, and probiotic products, with elimination of inflammatory foods. Ginger dosage was 1000 mg/day.Combination of the effect of ginger and anti-inflammatory diet on children with obesity with nonalcoholic fatty liver disease: A randomized clinical trial.
Human
children with obesity aged 8-11 yearsAID included fruits, vegetables, fish, lean meats, omega-3 sources, nuts, legumes, and probiotic products, with elimination of inflammatory foods. Ginger dosage was 1000 mg/day.Combination of the effect of ginger and anti-inflammatory diet on children with obesity with nonalcoholic fatty liver disease: A randomized clinical trial.
Human
Fourteen healthy males 35 to 55 years of age and 14 healthy postmenopausal women 50 to 60 years of age40-42% of energy from fat (26-28% from monounsaturated fat) in the sunflower oil diet.Effects of monounsaturated enriched sunflower oil on CHD risk factors including LDL size and copper-induced LDL oxidation.
Human
Fourteen healthy males 35 to 55 years of age and 14 healthy postmenopausal women 50 to 60 years of age40-42% of energy from fat (26-28% from monounsaturated fat) in the sunflower oil diet.Effects of monounsaturated enriched sunflower oil on CHD risk factors including LDL size and copper-induced LDL oxidation.
Human
Fourteen healthy males 35 to 55 years of age and 14 healthy postmenopausal women 50 to 60 years of age40-42% of energy from fat (26-28% from monounsaturated fat) in the sunflower oil diet.Effects of monounsaturated enriched sunflower oil on CHD risk factors including LDL size and copper-induced LDL oxidation.
Human
Fourteen healthy males 35 to 55 years of age and 14 healthy postmenopausal women 50 to 60 years of age40-42% of energy from fat (26-28% from monounsaturated fat) in the sunflower oil diet.Effects of monounsaturated enriched sunflower oil on CHD risk factors including LDL size and copper-induced LDL oxidation.
Human
Not specified (dietary intervention, not quantified).Non-soy legume consumption lowers cholesterol levels: a meta-analysis of randomized controlled trials.
Human
Not specified (dietary intervention, not quantified).Non-soy legume consumption lowers cholesterol levels: a meta-analysis of randomized controlled trials.
Human
free-living individuals with Type 2 diabetes mellitusMUFA diet (40% energy from fat, primarily virgin olive oil).Comparison of a high-carbohydrate and a high-monounsaturated fat, olive oil-rich diet on the susceptibility of LDL to oxidative modification in subjects with Type 2 diabetes mellitus.
Human
free-living individuals with Type 2 diabetes mellitusMUFA diet (40% energy from fat, primarily virgin olive oil).Comparison of a high-carbohydrate and a high-monounsaturated fat, olive oil-rich diet on the susceptibility of LDL to oxidative modification in subjects with Type 2 diabetes mellitus.
Human
free-living individuals with Type 2 diabetes mellitusMUFA diet (40% energy from fat, primarily virgin olive oil).Comparison of a high-carbohydrate and a high-monounsaturated fat, olive oil-rich diet on the susceptibility of LDL to oxidative modification in subjects with Type 2 diabetes mellitus.
Human
free-living individuals with Type 2 diabetes mellitusMUFA diet (40% energy from fat, primarily virgin olive oil).Comparison of a high-carbohydrate and a high-monounsaturated fat, olive oil-rich diet on the susceptibility of LDL to oxidative modification in subjects with Type 2 diabetes mellitus.
Human
free-living individuals with Type 2 diabetes mellitusMUFA diet (40% energy from fat, primarily virgin olive oil).Comparison of a high-carbohydrate and a high-monounsaturated fat, olive oil-rich diet on the susceptibility of LDL to oxidative modification in subjects with Type 2 diabetes mellitus.
Human
free-living individuals with Type 2 diabetes mellitusMUFA diet (40% energy from fat, primarily virgin olive oil).Comparison of a high-carbohydrate and a high-monounsaturated fat, olive oil-rich diet on the susceptibility of LDL to oxidative modification in subjects with Type 2 diabetes mellitus.
Human
free-living individuals with Type 2 diabetes mellitusMUFA diet (40% energy from fat, primarily virgin olive oil).Comparison of a high-carbohydrate and a high-monounsaturated fat, olive oil-rich diet on the susceptibility of LDL to oxidative modification in subjects with Type 2 diabetes mellitus.
Human
subjects with hypercholesterolemiaLow-fat diet (26% of energy from fat) supplemented with olive oil and olive oil-based margarine.A low-fat diet supplemented with monounsaturated fat results in less HDL-C lowering than a very-low-fat diet.
Human
subjects with hypercholesterolemiaLow-fat diet (26% of energy from fat) supplemented with olive oil and olive oil-based margarine.A low-fat diet supplemented with monounsaturated fat results in less HDL-C lowering than a very-low-fat diet.
Human
subjects with hypercholesterolemiaLow-fat diet (26% of energy from fat) supplemented with olive oil and olive oil-based margarine.A low-fat diet supplemented with monounsaturated fat results in less HDL-C lowering than a very-low-fat diet.
Human
subjects with hypercholesterolemiaLow-fat diet (26% of energy from fat) supplemented with olive oil and olive oil-based margarine.A low-fat diet supplemented with monounsaturated fat results in less HDL-C lowering than a very-low-fat diet.
Human
subjects with hypercholesterolemiaLow-fat diet (26% of energy from fat) supplemented with olive oil and olive oil-based margarine.A low-fat diet supplemented with monounsaturated fat results in less HDL-C lowering than a very-low-fat diet.
Human
subjects with hypercholesterolemiaLow-fat diet (26% of energy from fat) supplemented with olive oil and olive oil-based margarine.A low-fat diet supplemented with monounsaturated fat results in less HDL-C lowering than a very-low-fat diet.
Human
35-50 g oat bran daily.Effect of an oat bran enriched diet on the atherogenic lipid profile in patients with an increased coronary heart disease risk. A controlled randomized lifestyle intervention study.
Human
35-50 g oat bran daily.Effect of an oat bran enriched diet on the atherogenic lipid profile in patients with an increased coronary heart disease risk. A controlled randomized lifestyle intervention study.
Human
hypercholesterolemic adults30% of daily energy needs from either CSO or OO, provided via meals and snacks covering ~60% of daily energy requirements.Blood Lipid Responses to Diets Enriched with Cottonseed Oil Compared With Olive Oil in Adults with High Cholesterol in a Randomized Trial.
Human
hypercholesterolemic adults30% of daily energy needs from either CSO or OO, provided via meals and snacks covering ~60% of daily energy requirements.Blood Lipid Responses to Diets Enriched with Cottonseed Oil Compared With Olive Oil in Adults with High Cholesterol in a Randomized Trial.
Human
hypercholesterolemic adults30% of daily energy needs from either CSO or OO, provided via meals and snacks covering ~60% of daily energy requirements.Blood Lipid Responses to Diets Enriched with Cottonseed Oil Compared With Olive Oil in Adults with High Cholesterol in a Randomized Trial.
Human
hypercholesterolemic adults30% of daily energy needs from either CSO or OO, provided via meals and snacks covering ~60% of daily energy requirements.Blood Lipid Responses to Diets Enriched with Cottonseed Oil Compared With Olive Oil in Adults with High Cholesterol in a Randomized Trial.
Human
hypercholesterolemic adults30% of daily energy needs from either CSO or OO, provided via meals and snacks covering ~60% of daily energy requirements.Blood Lipid Responses to Diets Enriched with Cottonseed Oil Compared With Olive Oil in Adults with High Cholesterol in a Randomized Trial.
Human
individuals with type 2 diabetes mellitus (T2DM) and low habitual Ca consumption (<600 mg/d)Approximately 1200 mg/d (700 mg from fat-free milk + 500 mg from other dietary sources) for MD; 525 mg/d for CD.Effect of increased calcium consumption from fat-free milk in an energy-restricted diet on the metabolic syndrome and cardiometabolic outcomes in adults with type 2 diabetes mellitus: a randomised cross-over clinical trial.
Human
individuals with type 2 diabetes mellitus (T2DM) and low habitual Ca consumption (<600 mg/d)Approximately 1200 mg/d (700 mg from fat-free milk + 500 mg from other dietary sources) for MD; 525 mg/d for CD.Effect of increased calcium consumption from fat-free milk in an energy-restricted diet on the metabolic syndrome and cardiometabolic outcomes in adults with type 2 diabetes mellitus: a randomised cross-over clinical trial.
Human
individuals with type 2 diabetesNot specifiedA low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: a randomized, controlled, 74-wk clinical trial.
Human
individuals with type 2 diabetesNot specifiedA low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: a randomized, controlled, 74-wk clinical trial.
Human
individuals with type 2 diabetesNot specifiedA low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: a randomized, controlled, 74-wk clinical trial.
Human
individuals with type 2 diabetesNot specifiedA low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: a randomized, controlled, 74-wk clinical trial.
Human
type 2 diabetic patientsPreweighed diets with different GIs (specific amounts not detailed).Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients.
Human
type 2 diabetic patientsPreweighed diets with different GIs (specific amounts not detailed).Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients.
Human
type 2 diabetic patientsPreweighed diets with different GIs (specific amounts not detailed).Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients.
Human
women1 kg of Pleurotus ostreatus per week (four portions of 250 g).Dietary Supplementation with Oyster Culinary-Medicinal Mushroom, Pleurotus ostreatus (Agaricomycetes), Reduces Visceral Fat and Hyperlipidemia in Inhabitants of a Rural Community in Mexico.
Animal
zebrafish (Danio rerio)Not specifiedThe Potential Role of Intestinal Microbiota on the Intestine-Protective and Lipid-Lowering Effects of Berberine in Zebrafish (Danio rerio) Under High-Lipid Stress.
Human
eleven male volunteersNot specified (HF yogurt supplement used).Gastrointestinal transit, post-prandial lipaemia and satiety following 3 days high-fat diet in men.
Human
eleven male volunteersNot specified (HF yogurt supplement used).Gastrointestinal transit, post-prandial lipaemia and satiety following 3 days high-fat diet in men.
Human
eleven male volunteersNot specified (HF yogurt supplement used).Gastrointestinal transit, post-prandial lipaemia and satiety following 3 days high-fat diet in men.
Human
participants on a low-fat diet who had increased the percentage energy intake from protein600 kcal energy-deficient diets (low-fat: 20-25% fat; high-fat: 40-45% fat).Change in proportional protein intake in a 10-week energy-restricted low- or high-fat diet, in relation to changes in body size and metabolic factors.
Human
obese adults600 kcal energy-deficient diets (low-fat: 20-25% fat; high-fat: 40-45% fat).Change in proportional protein intake in a 10-week energy-restricted low- or high-fat diet, in relation to changes in body size and metabolic factors.
Human
overweight or obese patients with non-alcoholic fatty liver disease3 g/day (capsule form).The efficacy of sumac (Rhus coriaria L.) powder supplementation in biochemical and anthropometric measurements in overweight or obese patients with non-alcoholic fatty liver disease: A double-blind randomized controlled trial.
Human
olive oil-groupNot specified for sunflower oil (habitual culinary use).Olive oil-diet improves the simvastatin effects with respect to sunflower oil-diet in men with increased cardiovascular risk: a preliminary study.
Human
olive oil-groupNot specified for sunflower oil (habitual culinary use).Olive oil-diet improves the simvastatin effects with respect to sunflower oil-diet in men with increased cardiovascular risk: a preliminary study.
Human
olive oil-groupNot specified for sunflower oil (habitual culinary use).Olive oil-diet improves the simvastatin effects with respect to sunflower oil-diet in men with increased cardiovascular risk: a preliminary study.
Human
participants with the G alleleDiets with 20% (low-fat) or 40% (high-fat) of energy derived from fatAPOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost Trial.
Human
carriers of the risk allele (G allele)Diets with 20% (low-fat) or 40% (high-fat) of energy derived from fatAPOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost Trial.
Animal
mice on high fat dietsRice bran proteins and their hydrolysates modulate cholesterol metabolism in mice on hypercholesterolemic diets.
Animal
mice on high fat dietsRice bran proteins and their hydrolysates modulate cholesterol metabolism in mice on hypercholesterolemic diets.
Animal
mice on high fat dietsRice bran proteins and their hydrolysates modulate cholesterol metabolism in mice on hypercholesterolemic diets.
Animal
mice on high fat dietsRice bran proteins and their hydrolysates modulate cholesterol metabolism in mice on hypercholesterolemic diets.
Animal
mice on high fat dietsRice bran proteins and their hydrolysates modulate cholesterol metabolism in mice on hypercholesterolemic diets.
Animal
mice on high fat dietsRice bran proteins and their hydrolysates modulate cholesterol metabolism in mice on hypercholesterolemic diets.
Human
patients with previous myocardial infarction30 g/day (10 g peanuts, 10 g cashew, 10 g Brazil nuts).Effects of mixed nuts as part of a Brazilian Cardioprotective diet on LDL-cholesterol in adult patients after myocardial infarction: a multicenter randomized controlled clinical trial.
Human
men with MetS risk profile280 mg SDG (secoisolariciresinol diglucoside) supplemented with the rye diet at weeks 4-8.Effects of whole-grain wheat, rye, and lignan supplementation on cardiometabolic risk factors in men with metabolic syndrome: a randomized crossover trial.
Human
men with MetS risk profile280 mg SDG (secoisolariciresinol diglucoside) supplemented with the rye diet at weeks 4-8.Effects of whole-grain wheat, rye, and lignan supplementation on cardiometabolic risk factors in men with metabolic syndrome: a randomized crossover trial.
Human
45 overweight or obese participants with baseline LDL-C in the 25th to 90th percentileOne fresh Hass avocado (136 g) per day.Effect of a moderate fat diet with and without avocados on lipoprotein particle number, size and subclasses in overweight and obese adults: a randomized, controlled trial.
Human
45 overweight or obese participants with baseline LDL-C in the 25th to 90th percentileOne fresh Hass avocado (136 g) per day.Effect of a moderate fat diet with and without avocados on lipoprotein particle number, size and subclasses in overweight and obese adults: a randomized, controlled trial.
Human
45 overweight or obese participants with baseline LDL-C in the 25th to 90th percentileOne fresh Hass avocado (136 g) per day.Effect of a moderate fat diet with and without avocados on lipoprotein particle number, size and subclasses in overweight and obese adults: a randomized, controlled trial.
Human
PolesNot specifiedThe Change in the Content of Nutrients in Diets Eliminating Products of Animal Origin in Comparison to a Regular Diet from the Area of Middle-Eastern Europe.
Human
Not specifiedThe Change in the Content of Nutrients in Diets Eliminating Products of Animal Origin in Comparison to a Regular Diet from the Area of Middle-Eastern Europe.
Human
62 healthy persons aged 65-85 years2 capsules of VSL#3 per day (specific B12 dosage not specified).Impact of personalized diet and probiotic supplementation on inflammation, nutritional parameters and intestinal microbiota - The "RISTOMED project": Randomized controlled trial in healthy older people.
Human
adults with obesity<30% of daily energy from fat, <7% from saturated fat, 55% from carbohydrate, and an energy deficit of 500 kcal/day.Effect of ideal protein versus low-fat diet for weight loss: A randomized controlled trial.
Human
patients with type 2 diabetes mellitusNot specified (dietary intervention with brown rice vs. white rice).Fiber-rich diet with brown rice improves endothelial function in type 2 diabetes mellitus: A randomized controlled trial.
Human
patients with type 2 diabetes mellitusNot specified (dietary intervention with brown rice vs. white rice).Fiber-rich diet with brown rice improves endothelial function in type 2 diabetes mellitus: A randomized controlled trial.
Human
patients with type 2 diabetes mellitusNot specified (dietary intervention with brown rice vs. white rice).Fiber-rich diet with brown rice improves endothelial function in type 2 diabetes mellitus: A randomized controlled trial.
Human
38 women with obesityNot specified (Mediterranean diet supplemented with almonds).Positive Effects of a Mediterranean Diet Supplemented with Almonds on Female Adipose Tissue Biology in Severe Obesity.
Human
participants with cardiovascular risk factorsNot specified (dietary intervention included eight 90-minute group meetings and two 120-minute cooking sessions).Does a Plant-Based Diet Stand Out for Its Favorable Composition for Heart Health? Dietary Intake Data from a Randomized Controlled Trial.
Human
60-year-old man with typical angina and positive stress testNot specified (diet consisted primarily of vegetables, fruits, whole grains, potatoes, beans, legumes, and nuts).A Whole-Food Plant-Based Diet Reversed Angina without Medications or Procedures.
Human
participants referred to a "Food as Prevention" programNot specifiedImplementation of a Whole Food Plant Based Diet in a Food as Prevention Program in a Resource Constrained Environment.
Animal
Cobb-500 strain broilers finisher chickens0% (control), 3.75%, 7.5%, 11.25%, and 15% SPLM in diets.Antioxidant and antinutritional potentials of sweet potato (Ipomoea batatas) leaf meal on the growth performance, economics of production, blood indices, carcass characteristics and histopathology of broiler chickens.
Human
healthy European menDaily intake of 1410 mg (range 583-2642 mg) of trans alpha-linolenic acid in the high-trans group.Dietary trans alpha-linolenic acid from deodorised rapeseed oil and plasma lipids and lipoproteins in healthy men: the TransLinE Study.
Human
healthy European menDaily intake of 1410 mg (range 583-2642 mg) of trans alpha-linolenic acid in the high-trans group.Dietary trans alpha-linolenic acid from deodorised rapeseed oil and plasma lipids and lipoproteins in healthy men: the TransLinE Study.
Human
healthy European menDaily intake of 1410 mg (range 583-2642 mg) of trans alpha-linolenic acid in the high-trans group.Dietary trans alpha-linolenic acid from deodorised rapeseed oil and plasma lipids and lipoproteins in healthy men: the TransLinE Study.
Human
healthy European menDaily intake of 1410 mg (range 583-2642 mg) of trans alpha-linolenic acid in the high-trans group.Dietary trans alpha-linolenic acid from deodorised rapeseed oil and plasma lipids and lipoproteins in healthy men: the TransLinE Study.
Human
healthy European menDaily intake of 1410 mg (range 583-2642 mg) of trans alpha-linolenic acid in the high-trans group.Dietary trans alpha-linolenic acid from deodorised rapeseed oil and plasma lipids and lipoproteins in healthy men: the TransLinE Study.
Human
healthy European menDaily intake of 1410 mg (range 583-2642 mg) of trans alpha-linolenic acid in the high-trans group.Dietary trans alpha-linolenic acid from deodorised rapeseed oil and plasma lipids and lipoproteins in healthy men: the TransLinE Study.
Human
59 young subjects (30 men and 29 women)Not specified.A Mediterranean and a high-carbohydrate diet improve glucose metabolism in healthy young persons.
Human
59 young subjects (30 men and 29 women)Not specified.A Mediterranean and a high-carbohydrate diet improve glucose metabolism in healthy young persons.
Human
59 young subjects (30 men and 29 women)Not specified.A Mediterranean and a high-carbohydrate diet improve glucose metabolism in healthy young persons.
Human
59 young subjects (30 men and 29 women)Not specified.A Mediterranean and a high-carbohydrate diet improve glucose metabolism in healthy young persons.
Human
overweight/obese individuals with type 2 diabetesHigh-protein diet (30% total energy), high-carbohydrate diet (55% total energy).The effect of high-protein, low-carbohydrate diets in the treatment of type 2 diabetes: a 12 month randomised controlled trial.
Human
overweight/obese individuals with type 2 diabetesHigh-protein diet (30% total energy), high-carbohydrate diet (55% total energy).The effect of high-protein, low-carbohydrate diets in the treatment of type 2 diabetes: a 12 month randomised controlled trial.
Human
overweight/obese individuals with type 2 diabetesHigh-protein diet (30% total energy), high-carbohydrate diet (55% total energy).The effect of high-protein, low-carbohydrate diets in the treatment of type 2 diabetes: a 12 month randomised controlled trial.
Human
overweight/obese individuals with type 2 diabetesHigh-protein diet (30% total energy), high-carbohydrate diet (55% total energy).The effect of high-protein, low-carbohydrate diets in the treatment of type 2 diabetes: a 12 month randomised controlled trial.
Animal
male Wistar ratsNot specifiedWhole tomato lipidic extract improved sperm quality in obese rats induced by a high-carbohydrate diet.
Human
Mexican adults with MeS1.34 g/kg body weight (HPD) vs. 0.8 g/kg body weight (SPD).Effect of a High-Protein Diet versus Standard-Protein Diet on Weight Loss and Biomarkers of Metabolic Syndrome: A Randomized Clinical Trial.
Human
Mexican adults with MeS1.34 g/kg body weight (HPD) vs. 0.8 g/kg body weight (SPD).Effect of a High-Protein Diet versus Standard-Protein Diet on Weight Loss and Biomarkers of Metabolic Syndrome: A Randomized Clinical Trial.
Human
hyperlipidemic patientsNot specified (food prepared daily based on individual energy requirements).Similar effects of rapeseed oil (canola oil) and olive oil in a lipid-lowering diet for patients with hyperlipoproteinemia.
Human
hyperlipidemic patientsNot specified (food prepared daily based on individual energy requirements).Similar effects of rapeseed oil (canola oil) and olive oil in a lipid-lowering diet for patients with hyperlipoproteinemia.
Human
hyperlipidemic patientsNot specified (food prepared daily based on individual energy requirements).Similar effects of rapeseed oil (canola oil) and olive oil in a lipid-lowering diet for patients with hyperlipoproteinemia.
Human
hyperlipidemic patientsNot specified (food prepared daily based on individual energy requirements).Similar effects of rapeseed oil (canola oil) and olive oil in a lipid-lowering diet for patients with hyperlipoproteinemia.
Human
hyperlipidemic patientsNot specified (food prepared daily based on individual energy requirements).Similar effects of rapeseed oil (canola oil) and olive oil in a lipid-lowering diet for patients with hyperlipoproteinemia.
Human
hyperlipidemic patientsNot specified (food prepared daily based on individual energy requirements).Similar effects of rapeseed oil (canola oil) and olive oil in a lipid-lowering diet for patients with hyperlipoproteinemia.
Animal
offspring50 mg/kg FA daily.Ferulic acid protects rat offspring from maternal high-fat, high-fructose diet-induced toxicity and developmental retardation through a direct effect on pancreatic islets.
Animal
ICR miceHepatoprotective activity of scutellariae radix extract in mice fed a high fat diet with chronic alcohol exposure.
Human
118 men homozygous for FADS1 rs174550 SNP (TT or CC)30-50 mL/day of Camelina sativa oil (ALA diet) or sunflower oil (LA diet), adjusted by BMI.Dietary n-3 alpha-linolenic and n-6 linoleic acids modestly lower serum lipoprotein(a) concentration but differentially influence other atherogenic lipoprotein traits: A randomized trial.
Human
52 subjects treated with NCsOnce-daily oral formulation (specific dosage not detailed).Effect of Monacolin K and COQ10 supplementation in hypertensive and hypercholesterolemic subjects with metabolic syndrome.
Human
obese patients with CC genotype of ADIPOQ gene variant rs266729High-fat diet (38% fats), low-fat diet (27% fats)Adiponectin Gene Variant rs266729 Interacts with Different Macronutrient Distribution of Two Different Hypocaloric Diets.
Human
obese patients with CC genotype of ADIPOQ gene variant rs266729High-fat diet (38% fats), low-fat diet (27% fats)Adiponectin Gene Variant rs266729 Interacts with Different Macronutrient Distribution of Two Different Hypocaloric Diets.
Human
obese patients with NASHNot specified (intervention involved moderate aerobic exercise and diet regimen).Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.
Human
obese patients with NASHNot specified (intervention involved moderate aerobic exercise and diet regimen).Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.
Human
obese patients with NASHNot specified (intervention involved moderate aerobic exercise and diet regimen).Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.
Human
MAO womenNot specified (intervention was an energy-restricted diet, not alanine supplementation).A weight loss diet intervention has a similar beneficial effect on both metabolically abnormal obese and metabolically healthy but obese premenopausal women.
Human
obese subjects with type 2 diabetes (T2D)≥6 portions/day of fruits and vegetables (specific lutein dosage not isolated).A randomised controlled trial of increasing fruit and vegetable intake and how this influences the carotenoid concentration and activities of PON-1 and LCAT in HDL from subjects with type 2 diabetes.
Animal
diabetic ratsYacon roots (Smallanthus sonchifolius) improve oxidative stress in diabetic rats.
Human
adults with metabolic syndromePLCD (25-30% carbohydrate, 30% protein, 40-45% fat); MCD (40-45% carbohydrate, 30% protein, 30-35% fat).Effect of Paleolithic-based low-carbohydrate vs. moderate-carbohydrate diets with portion-control and calorie-counting on CTRP6, asprosin and metabolic markers in adults with metabolic syndrome: A randomized clinical trial.
Human
adults with metabolic syndromePLCD (25-30% carbohydrate, 30% protein, 40-45% fat); MCD (40-45% carbohydrate, 30% protein, 30-35% fat).Effect of Paleolithic-based low-carbohydrate vs. moderate-carbohydrate diets with portion-control and calorie-counting on CTRP6, asprosin and metabolic markers in adults with metabolic syndrome: A randomized clinical trial.
Human
adults with metabolic syndromePLCD (25-30% carbohydrate, 30% protein, 40-45% fat); MCD (40-45% carbohydrate, 30% protein, 30-35% fat).Effect of Paleolithic-based low-carbohydrate vs. moderate-carbohydrate diets with portion-control and calorie-counting on CTRP6, asprosin and metabolic markers in adults with metabolic syndrome: A randomized clinical trial.
Human
adults with metabolic syndromePLCD (25-30% carbohydrate, 30% protein, 40-45% fat); MCD (40-45% carbohydrate, 30% protein, 30-35% fat).Effect of Paleolithic-based low-carbohydrate vs. moderate-carbohydrate diets with portion-control and calorie-counting on CTRP6, asprosin and metabolic markers in adults with metabolic syndrome: A randomized clinical trial.
Human
adults with metabolic syndromePLCD (25-30% carbohydrate, 30% protein, 40-45% fat); MCD (40-45% carbohydrate, 30% protein, 30-35% fat).Effect of Paleolithic-based low-carbohydrate vs. moderate-carbohydrate diets with portion-control and calorie-counting on CTRP6, asprosin and metabolic markers in adults with metabolic syndrome: A randomized clinical trial.
Human
adults with metabolic syndromePLCD (25-30% carbohydrate, 30% protein, 40-45% fat); MCD (40-45% carbohydrate, 30% protein, 30-35% fat).Effect of Paleolithic-based low-carbohydrate vs. moderate-carbohydrate diets with portion-control and calorie-counting on CTRP6, asprosin and metabolic markers in adults with metabolic syndrome: A randomized clinical trial.
Human
adults with metabolic syndromePLCD (25-30% carbohydrate, 30% protein, 40-45% fat); MCD (40-45% carbohydrate, 30% protein, 30-35% fat).Effect of Paleolithic-based low-carbohydrate vs. moderate-carbohydrate diets with portion-control and calorie-counting on CTRP6, asprosin and metabolic markers in adults with metabolic syndrome: A randomized clinical trial.
Human
adults with metabolic syndromePLCD (25-30% carbohydrate, 30% protein, 40-45% fat); MCD (40-45% carbohydrate, 30% protein, 30-35% fat).Effect of Paleolithic-based low-carbohydrate vs. moderate-carbohydrate diets with portion-control and calorie-counting on CTRP6, asprosin and metabolic markers in adults with metabolic syndrome: A randomized clinical trial.
Human
diet groupTotal fat intake averaged ~15% of total calories.Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.
Human
diet groupTotal fat intake averaged ~15% of total calories.Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.
Human
stable CAD patients who were overweight or obeseNot specified (nuts included as part of a 25% energy-deficit diet).A calorie-restricted diet with nuts favourably raises plasma high-density lipoprotein-cholesterol in overweight and obese patients with stable coronary heart disease: A randomised controlled trial.
Human
stable CAD patients who were overweight or obeseNot specified (nuts included as part of a 25% energy-deficit diet).A calorie-restricted diet with nuts favourably raises plasma high-density lipoprotein-cholesterol in overweight and obese patients with stable coronary heart disease: A randomised controlled trial.
Human
stable CAD patients who were overweight or obeseNot specified (nuts included as part of a 25% energy-deficit diet).A calorie-restricted diet with nuts favourably raises plasma high-density lipoprotein-cholesterol in overweight and obese patients with stable coronary heart disease: A randomised controlled trial.
Human
stable CAD patients who were overweight or obeseNot specified (nuts included as part of a 25% energy-deficit diet).A calorie-restricted diet with nuts favourably raises plasma high-density lipoprotein-cholesterol in overweight and obese patients with stable coronary heart disease: A randomised controlled trial.
Human
stable CAD patients who were overweight or obeseNot specified (nuts included as part of a 25% energy-deficit diet).A calorie-restricted diet with nuts favourably raises plasma high-density lipoprotein-cholesterol in overweight and obese patients with stable coronary heart disease: A randomised controlled trial.
Human
women with PCOSNot specifiedDietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines.
Human
women with PCOSNot specifiedDietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines.
Human
women with PCOSNot specifiedDietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines.
Human
women with PCOSNot specifiedDietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines.
Human
subjects with well-controlled non-insulin-dependent diabetes mellitus (NIDDM) and normal lipid profileNot specified (diets were matched for macronutrient composition and fiber).Low-glycemic index foods improve long-term glycemic control in NIDDM.
Human
overweight and obese individuals with increased waist circumference and one or more other MetS criteriaNot specifiedEffects of whole and refined grains in a weight-loss diet on markers of metabolic syndrome in individuals with increased waist circumference: a randomized controlled-feeding trial.
Human
compliant individualsNot specifiedEffects of whole and refined grains in a weight-loss diet on markers of metabolic syndrome in individuals with increased waist circumference: a randomized controlled-feeding trial.
AnimalMolecular
Male mice1% SCE in diet for mice; non-toxic concentrations of SA for HepG2 cells (specific amounts not provided).Schisandrin A in Schisandra chinensis Upregulates the LDL Receptor by Inhibiting PCSK9 Protein Stabilization in Steatotic Model.
Animal
miceNot specifiedCisd2 Protects the Liver from Oxidative Stress and Ameliorates Western Diet-Induced Nonalcoholic Fatty Liver Disease.
Animal
C57BL/6J (WT) miceNot specifiedLymphatic Valve Dysfunction in Western Diet-Fed Mice: New Insights Into Obesity-Induced Lymphedema.
Human
subjects with baseline LDL cholesterol in the 50th to 95th percentile28 g (1 oz) twice dailyRandomized, controlled, crossover trial of oat bran in hypercholesterolemic subjects.
Human
subjects with baseline LDL cholesterol in the 50th to 95th percentile28 g (1 oz) twice dailyRandomized, controlled, crossover trial of oat bran in hypercholesterolemic subjects.
Human
Women under the age of 50 years28 g (1 oz) twice dailyRandomized, controlled, crossover trial of oat bran in hypercholesterolemic subjects.
Human
most hypercholesterolemic subjects28 g (1 oz) twice dailyRandomized, controlled, crossover trial of oat bran in hypercholesterolemic subjects.
Human
most hypercholesterolemic subjects28 g (1 oz) twice dailyRandomized, controlled, crossover trial of oat bran in hypercholesterolemic subjects.
Human
older women28 g (1 oz) twice dailyRandomized, controlled, crossover trial of oat bran in hypercholesterolemic subjects.
Human
patients with MASLD30 g/day of flaxseed powder.Effectiveness of flaxseed consumption and fasting mimicking diet on anthropometric measures, biochemical parameters, and hepatic features in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): a randomized controlled clinical trial.
Human
postmenopausal womenDiets were equivalent in energy, protein, and fat, with at least 80% of protein from dairy.The effect of dietary protein source on serum lipids: Secondary data analysis from a randomized clinical trial.
Human
postmenopausal womenDiets were equivalent in energy, protein, and fat, with at least 80% of protein from dairy.The effect of dietary protein source on serum lipids: Secondary data analysis from a randomized clinical trial.
Animal
VLCAD-knock-out (KO) miceNot specified (MCT diet and MCT-bolus, exact amounts not detailed).Medium-chain triglycerides impair lipid metabolism and induce hepatic steatosis in very long-chain acyl-CoA dehydrogenase (VLCAD)-deficient mice.
Animal
obese ratsEffects of fibre-enriched diets on tissue lipid profiles of MSG obese rats.
Animal
obese ratsEffects of fibre-enriched diets on tissue lipid profiles of MSG obese rats.
Human
men with obesity1 tablespoon (12 mL) dailyEffect of coconut oil on weight loss and metabolic parameters in men with obesity: a randomized controlled clinical trial.
Human
men with obesity1 tablespoon (12 mL) dailyEffect of coconut oil on weight loss and metabolic parameters in men with obesity: a randomized controlled clinical trial.
Human
CKD patientsLPD (0.6 g/kg/day) plus inulin (19 g/day) for the intervention group; LPD alone for controls.Prebiotic Therapy with Inulin Associated with Low Protein Diet in Chronic Kidney Disease Patients: Evaluation of Nutritional, Cardiovascular and Psychocognitive Parameters.
Human
eighty-one patients with the metabolic syndromeALA intake of 3.5 g/day via rapeseed oil.Effects of a rapeseed oil-enriched hypoenergetic diet with a high content of α-linolenic acid on body weight and cardiovascular risk profile in patients with the metabolic syndrome.
Human
eighty-one patients with the metabolic syndromeALA intake of 3.5 g/day via rapeseed oil.Effects of a rapeseed oil-enriched hypoenergetic diet with a high content of α-linolenic acid on body weight and cardiovascular risk profile in patients with the metabolic syndrome.
Human
eighty-one patients with the metabolic syndromeALA intake of 3.5 g/day via rapeseed oil.Effects of a rapeseed oil-enriched hypoenergetic diet with a high content of α-linolenic acid on body weight and cardiovascular risk profile in patients with the metabolic syndrome.
Human
eighty-one patients with the metabolic syndromeALA intake of 3.5 g/day via rapeseed oil.Effects of a rapeseed oil-enriched hypoenergetic diet with a high content of α-linolenic acid on body weight and cardiovascular risk profile in patients with the metabolic syndrome.
Human
young and healthy adultsLess than 20g carbohydrates per day.Effect of low carbohydrate high fat diet on LDL cholesterol and gene expression in normal-weight, young adults: A randomized controlled study.
Human
young and healthy adultsLess than 20g carbohydrates per day.Effect of low carbohydrate high fat diet on LDL cholesterol and gene expression in normal-weight, young adults: A randomized controlled study.
Human
young and healthy adultsLess than 20g carbohydrates per day.Effect of low carbohydrate high fat diet on LDL cholesterol and gene expression in normal-weight, young adults: A randomized controlled study.
Human
men with cardiovascular risk factors60g of flaxseed powder per day.Impact of weight loss diet associated with flaxseed on inflammatory markers in men with cardiovascular risk factors: a clinical study.
Animal
rats30% high-protein diet; resveratrol dosage not specified.Effects of High-Protein Diet and/or Resveratrol Supplementation on the Immune Response of Irradiated Rats.
Human
non-T-allele carriers (GG genotype)Not specifiedThe effect of single-nucleotide polymorphisms at the ADIPOQ gene locus rs1501299 on metabolic parameters after 9 mo of a high-protein/low-carbohydrate versus a standard hypocaloric diet.
Human
T-allele carriers (GT and TT genotypes)Not specifiedThe effect of single-nucleotide polymorphisms at the ADIPOQ gene locus rs1501299 on metabolic parameters after 9 mo of a high-protein/low-carbohydrate versus a standard hypocaloric diet.
Human
non-T-allele carriers (GG genotype)Not specifiedThe effect of single-nucleotide polymorphisms at the ADIPOQ gene locus rs1501299 on metabolic parameters after 9 mo of a high-protein/low-carbohydrate versus a standard hypocaloric diet.
Human
T-allele carriers (GT and TT genotypes)Not specifiedThe effect of single-nucleotide polymorphisms at the ADIPOQ gene locus rs1501299 on metabolic parameters after 9 mo of a high-protein/low-carbohydrate versus a standard hypocaloric diet.
Human
non-T-allele carriers (GG genotype)Not specifiedThe effect of single-nucleotide polymorphisms at the ADIPOQ gene locus rs1501299 on metabolic parameters after 9 mo of a high-protein/low-carbohydrate versus a standard hypocaloric diet.
Human
T-allele carriers (GT and TT genotypes)Not specifiedThe effect of single-nucleotide polymorphisms at the ADIPOQ gene locus rs1501299 on metabolic parameters after 9 mo of a high-protein/low-carbohydrate versus a standard hypocaloric diet.
Human
non-T-allele carriers (GG genotype)Not specifiedThe effect of single-nucleotide polymorphisms at the ADIPOQ gene locus rs1501299 on metabolic parameters after 9 mo of a high-protein/low-carbohydrate versus a standard hypocaloric diet.
Human
T-allele carriers (GT and TT genotypes)Not specifiedThe effect of single-nucleotide polymorphisms at the ADIPOQ gene locus rs1501299 on metabolic parameters after 9 mo of a high-protein/low-carbohydrate versus a standard hypocaloric diet.
Animal
azoxymethane-treated miceNot specified in the abstract.St. John's Wort Attenuates Colorectal Carcinogenesis in Mice through Suppression of Inflammatory Signaling.
Animal
chickens100 ppm and 300 ppm Aloe vera powder mixed into feedProtective effects of Aloe vera powder supplementation on some quantitative and qualitative characteristics of egg, histopathological changes and serum biochemistry of laying hens fed by Aflatoxin B1.
Human
subjects eating living foodNot specifiedVegan diet in physiological health promotion.
Human
23 obese adult womenNot specified (participants followed a typical 7-day meal plan with flexibility).Effect of Low-Carbohydrate Diet on Beta-Hydroxybutyrate Ketogenesis Metabolic Stimulation and Regulation of NLRP3 Ubiquitination in Obese Saudi Women.
Human
23 obese adult womenNot specified (participants followed a typical 7-day meal plan with flexibility).Effect of Low-Carbohydrate Diet on Beta-Hydroxybutyrate Ketogenesis Metabolic Stimulation and Regulation of NLRP3 Ubiquitination in Obese Saudi Women.
Human
23 obese adult womenNot specified (participants followed a typical 7-day meal plan with flexibility).Effect of Low-Carbohydrate Diet on Beta-Hydroxybutyrate Ketogenesis Metabolic Stimulation and Regulation of NLRP3 Ubiquitination in Obese Saudi Women.
Human
women diagnosed with PCOSNot specifiedThe effects of ketogenic diet on metabolic and hormonal parameters in patients with polycystic ovary syndrome: a systematic review and meta-analysis of clinical trials.
Human
women diagnosed with PCOSNot specifiedThe effects of ketogenic diet on metabolic and hormonal parameters in patients with polycystic ovary syndrome: a systematic review and meta-analysis of clinical trials.
Human
humansNot AssessedNovel Nutritional and Dietary Approaches to Weight Loss for the Prevention of Cardiovascular Disease: Ketogenic Diet, Intermittent Fasting, and Bariatric Surgery.
Human
Overweight or obese outpatients from the Department of Veterans Affairs primary care clinics in Durham, North CarolinaLow-fat diet (<30% energy from fat, 500-1000 kcal/d deficit) combined with orlistat (120 mg orally 3 times daily).A randomized trial of a low-carbohydrate diet vs orlistat plus a low-fat diet for weight loss.
Human
Overweight or obese outpatients from the Department of Veterans Affairs primary care clinics in Durham, North CarolinaLow-fat diet (<30% energy from fat, 500-1000 kcal/d deficit) combined with orlistat (120 mg orally 3 times daily).A randomized trial of a low-carbohydrate diet vs orlistat plus a low-fat diet for weight loss.
Human
Overweight or obese outpatients from the Department of Veterans Affairs primary care clinics in Durham, North CarolinaLow-fat diet (<30% energy from fat, 500-1000 kcal/d deficit) combined with orlistat (120 mg orally 3 times daily).A randomized trial of a low-carbohydrate diet vs orlistat plus a low-fat diet for weight loss.
Animal
type 2 diabetic mice (db/db)Effects of buckwheat sprouts on plasma and hepatic parameters in type 2 diabetic db/db mice.
Animal
type 2 diabetic mice (db/db)Effects of buckwheat sprouts on plasma and hepatic parameters in type 2 diabetic db/db mice.
Animal
type 2 diabetic mice (db/db)Effects of buckwheat sprouts on plasma and hepatic parameters in type 2 diabetic db/db mice.
Human
participants with metabolic syndrome3.3 servings/day of low-fat or full-fat milk, yogurt, and cheese.Impact of low-fat and full-fat dairy foods on fasting lipid profile and blood pressure: exploratory endpoints of a randomized controlled trial.
Human
participants with metabolic syndrome3.3 servings/day of low-fat or full-fat milk, yogurt, and cheese.Impact of low-fat and full-fat dairy foods on fasting lipid profile and blood pressure: exploratory endpoints of a randomized controlled trial.
Human
participants with metabolic syndrome3.3 servings/day of low-fat or full-fat milk, yogurt, and cheese.Impact of low-fat and full-fat dairy foods on fasting lipid profile and blood pressure: exploratory endpoints of a randomized controlled trial.
Human
subjects diagnosed with MESNot specifiedThe Effect of Gluten Free Diet on Components of Metabolic Syndrome: A Randomized Clinical Trial.
Human
subjects diagnosed with MESNot specifiedThe Effect of Gluten Free Diet on Components of Metabolic Syndrome: A Randomized Clinical Trial.
Human
children with T1DM and CDNot specifiedWhole lipid profile and not only HDL cholesterol is impaired in children with coexisting type 1 diabetes and untreated celiac disease.
Human
patients with celiac diseaseNot AssessedEffect of the gluten-free diet on cardiovascular risk factors in patients with coeliac disease: A systematic review.
Human
20 patients with dyslipoproteinemia type IIa and IIbNot specified[Feasibility of correcting lipid metabolism in patients with cardiovascular diseases using a balanced vegetarian diet].
Human
LFD aimed for 55-60 energy per cent (E%) from carbohydrates.In type 2 diabetes, randomisation to advice to follow a low-carbohydrate diet transiently improves glycaemic control compared with advice to follow a low-fat diet producing a similar weight loss.
Human
LFD aimed for 55-60 energy per cent (E%) from carbohydrates.In type 2 diabetes, randomisation to advice to follow a low-carbohydrate diet transiently improves glycaemic control compared with advice to follow a low-fat diet producing a similar weight loss.
Human
LFD aimed for 55-60 energy per cent (E%) from carbohydrates.In type 2 diabetes, randomisation to advice to follow a low-carbohydrate diet transiently improves glycaemic control compared with advice to follow a low-fat diet producing a similar weight loss.
Animal
Miniature Schnauzer with hypertriglyceridemiaNot specified (commercially available low-fat diet).Effect of a low-fat diet on serum triglyceride and cholesterol concentrations and lipoprotein profiles in Miniature Schnauzers with hypertriglyceridemia.
Animal
Miniature Schnauzer with hypertriglyceridemiaNot specified (commercially available low-fat diet).Effect of a low-fat diet on serum triglyceride and cholesterol concentrations and lipoprotein profiles in Miniature Schnauzers with hypertriglyceridemia.
Human
participants randomized to low-fat dietsNot specifiedEffects of low-fat diet on serum lipids in premenopausal and postmenopausal women: a meta-analysis of randomized controlled trials.
Human
wild-type group (G1359G)Not specifiedRole of G1359A polymorphism of the cannabinoid receptor gene on weight loss and adipocytokines levels after two different hypocaloric diets.
Human
wild-type group (G1359G)Not specifiedRole of G1359A polymorphism of the cannabinoid receptor gene on weight loss and adipocytokines levels after two different hypocaloric diets.
Human
patients with type 2 diabetes60 g soy nut daily as part of daily protein intake.The effect of soy nut on serum total antioxidant, endothelial function and cardiovascular risk factors in patients with type 2 diabetes.
Human
362 Caucasian patients with obesityNot specified.APOA-5 genetic variant and a hypocaloric diet enriched in ω-6 fatty acids with Mediterranean pattern.
Human
362 Caucasian patients with obesityNot specified.APOA-5 genetic variant and a hypocaloric diet enriched in ω-6 fatty acids with Mediterranean pattern.
Human
hyperlipidaemic subjectsNot specifiedReplacing dairy fat with rapeseed oil causes rapid improvement of hyperlipidaemia: a randomized controlled study.
Human
hyperlipidaemic subjectsNot specifiedReplacing dairy fat with rapeseed oil causes rapid improvement of hyperlipidaemia: a randomized controlled study.
Human
hyperlipidaemic subjectsNot specifiedReplacing dairy fat with rapeseed oil causes rapid improvement of hyperlipidaemia: a randomized controlled study.
Human
hyperlipidaemic subjectsNot specifiedReplacing dairy fat with rapeseed oil causes rapid improvement of hyperlipidaemia: a randomized controlled study.
Human
hyperlipidaemic subjectsNot specifiedReplacing dairy fat with rapeseed oil causes rapid improvement of hyperlipidaemia: a randomized controlled study.
Human
hyperlipidaemic subjectsNot specifiedReplacing dairy fat with rapeseed oil causes rapid improvement of hyperlipidaemia: a randomized controlled study.
Human
hyperlipidaemic subjectsNot specifiedReplacing dairy fat with rapeseed oil causes rapid improvement of hyperlipidaemia: a randomized controlled study.
Animal
Sprague-Dawley ratsNot specified (diet enriched with olive oil).Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats.
Human
Eighteen young, healthy men50 g of oil per 10 MJ incorporated into a constant dietAn olive oil-rich diet results in higher concentrations of LDL cholesterol and a higher number of LDL subfraction particles than rapeseed oil and sunflower oil diets.
Human
Eighteen young, healthy men50 g of oil per 10 MJ incorporated into a constant dietAn olive oil-rich diet results in higher concentrations of LDL cholesterol and a higher number of LDL subfraction particles than rapeseed oil and sunflower oil diets.
Human
Eighteen young, healthy men50 g of oil per 10 MJ incorporated into a constant dietAn olive oil-rich diet results in higher concentrations of LDL cholesterol and a higher number of LDL subfraction particles than rapeseed oil and sunflower oil diets.
Human
Eighteen young, healthy men50 g of oil per 10 MJ incorporated into a constant dietAn olive oil-rich diet results in higher concentrations of LDL cholesterol and a higher number of LDL subfraction particles than rapeseed oil and sunflower oil diets.
Human
six men and six women21 g safflower oil daily (providing 16 g LA/d).Safflower oil consumption does not increase plasma conjugated linoleic acid concentrations in humans.
Human
six men and six women21 g safflower oil daily (providing 16 g LA/d).Safflower oil consumption does not increase plasma conjugated linoleic acid concentrations in humans.
Human
younger adults with obesityNot specifiedMetabolic and Hepatic Effects of Energy-Reduced Anti-Inflammatory Diet in Younger Adults with Obesity.
Human
10 patients affected by familial endogenous hypertriglyceridemiaApproximately 60% of energy as carbohydrate (isocaloric diet).Long-term effect of a low-fat, high-carbohydrate diet on plasma lipids of patients affected by familial endogenous hypertriglyceridemia.
Human
10 patients affected by familial endogenous hypertriglyceridemiaApproximately 60% of energy as carbohydrate (isocaloric diet).Long-term effect of a low-fat, high-carbohydrate diet on plasma lipids of patients affected by familial endogenous hypertriglyceridemia.
Human
10 patients affected by familial endogenous hypertriglyceridemiaApproximately 60% of energy as carbohydrate (isocaloric diet).Long-term effect of a low-fat, high-carbohydrate diet on plasma lipids of patients affected by familial endogenous hypertriglyceridemia.
Human
10 patients affected by familial endogenous hypertriglyceridemiaApproximately 60% of energy as carbohydrate (isocaloric diet).Long-term effect of a low-fat, high-carbohydrate diet on plasma lipids of patients affected by familial endogenous hypertriglyceridemia.
Human
forty healthy subjectsNot specified (diet contained at least 25 g of relevant fat or was low-fat, high-carbohydrate)Flow-mediated dilatation is impaired by a high-saturated fat diet but not by a high-carbohydrate diet.
Human
overweight women with diagnosis of PCOSNot specified (ketogenic Mediterranean diet with phyoextracts).Effects of a ketogenic diet in overweight women with polycystic ovary syndrome.
Human
compliant adult patientsNot specifiedNutritional Counseling and Mediterranean Diet in Adrenoleukodystrophy: A Real-Life Experience.
Human
58 male patients with mild to moderate hypercholesterolemiaNot specified (incorporated into diet as breakfast cereals).Cholesterol-lowering effects of soluble-fiber cereals as part of a prudent diet for patients with mild to moderate hypercholesterolemia.
Human
participants with coronary artery diseaseNot specified (dietary intervention with provided groceries and counseling).Anti-Inflammatory Effects of a Vegan Diet Versus the American Heart Association-Recommended Diet in Coronary Artery Disease Trial.
Human
Not specifiedAssessing the independent effect of dietary counseling and hypolipidemic medications on serum lipids.
Human
subjects with ≥2 MetS risk factors80 g cheese/10 MJ daily for REG and RED groups; 90 g bread and 25 g jam/10 MJ daily for CHO group.High intake of regular-fat cheese compared with reduced-fat cheese does not affect LDL cholesterol or risk markers of the metabolic syndrome: a randomized controlled trial.
Human
subjects with ≥2 MetS risk factors80 g cheese/10 MJ daily for REG and RED groups; 90 g bread and 25 g jam/10 MJ daily for CHO group.High intake of regular-fat cheese compared with reduced-fat cheese does not affect LDL cholesterol or risk markers of the metabolic syndrome: a randomized controlled trial.
Human
subjects with ≥2 MetS risk factors80 g cheese/10 MJ daily for REG and RED groups; 90 g bread and 25 g jam/10 MJ daily for CHO group.High intake of regular-fat cheese compared with reduced-fat cheese does not affect LDL cholesterol or risk markers of the metabolic syndrome: a randomized controlled trial.
Human
subjects with ≥2 MetS risk factors80 g cheese/10 MJ daily for REG and RED groups; 90 g bread and 25 g jam/10 MJ daily for CHO group.High intake of regular-fat cheese compared with reduced-fat cheese does not affect LDL cholesterol or risk markers of the metabolic syndrome: a randomized controlled trial.
Human
participants<40g net carbohydrates for the first 3 months, <40-60g net carbohydrates for months 3-6.Low-carbohydrate dietary pattern on glycemic outcomes trial (ADEPT) among individuals with elevated hemoglobin A1c: study protocol for a randomized controlled trial.
Human
CCI groupNot specifiedImpact of a 2-year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetes.
Human
patients with type 2 diabetes (T2D)Not specifiedImpact of a 2-year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetes.
Human
Thirty healthy, free-living, nonsmoking men and women from the Melbourne, Australia, metropolitan regionNot specifiedDiet high in monounsaturated fat does not have a different effect on arterial elasticity than a low-fat, high-carbohydrate diet.
Human
Thirty healthy, free-living, nonsmoking men and women from the Melbourne, Australia, metropolitan regionNot specifiedDiet high in monounsaturated fat does not have a different effect on arterial elasticity than a low-fat, high-carbohydrate diet.
Human
Thirty healthy, free-living, nonsmoking men and women from the Melbourne, Australia, metropolitan regionNot specifiedDiet high in monounsaturated fat does not have a different effect on arterial elasticity than a low-fat, high-carbohydrate diet.
Human
Nine healthy male volunteers with BMI ≤25 kg/m²Not specifiedCoconut oil consumption improves fat-free mass, plasma HDL-cholesterol and insulin sensitivity in healthy men with normal BMI compared to peanut oil.
AnimalMolecular
wild-type miceHigh-BCAA diet (specific dosage not detailed in abstract).Branched-chain amino acids promote hepatic Cyp7a1 expression and bile acid synthesis via suppressing FGF21-ERK pathway.
Human
obese womenNot specifiedOlive Leaf Extract Supplementation Combined with Calorie-Restricted Diet on Reducing Body Weight and Fat Mass in Obese Women: Result of a Randomized Control Trial.
Human
obese womenNot specifiedOlive Leaf Extract Supplementation Combined with Calorie-Restricted Diet on Reducing Body Weight and Fat Mass in Obese Women: Result of a Randomized Control Trial.
Human
obese womenNot specifiedOlive Leaf Extract Supplementation Combined with Calorie-Restricted Diet on Reducing Body Weight and Fat Mass in Obese Women: Result of a Randomized Control Trial.
Human
21 (11 female,10 male) healthy participantsIndividual caloric needs met; exact amounts not specified.A 48-Hour Vegan Diet Challenge in Healthy Women and Men Induces a BRANCH-Chain Amino Acid Related, Health Associated, Metabolic Signature.
Human
vegan children and adolescents aged 0 to 18 yearsNot specifiedHealth aspects of vegan diets among children and adolescents: a systematic review and meta-analyses.
Human
Not specifiedThe Effect of a Vegan Diet on the Health Indicators and Outcomes of Patients with Type 2 Diabetes Mellitus.
Human
participants with no medication changesNot specifiedA Mediterranean Diet and Low-Fat Vegan Diet to Improve Body Weight and Cardiometabolic Risk Factors: A Randomized, Cross-over Trial.
Human
participants with no medication changesNot specifiedA Mediterranean Diet and Low-Fat Vegan Diet to Improve Body Weight and Cardiometabolic Risk Factors: A Randomized, Cross-over Trial.
Human
participants with no medication changesNot specifiedA Mediterranean Diet and Low-Fat Vegan Diet to Improve Body Weight and Cardiometabolic Risk Factors: A Randomized, Cross-over Trial.
Human
participants with no medication changesNot specifiedA Mediterranean Diet and Low-Fat Vegan Diet to Improve Body Weight and Cardiometabolic Risk Factors: A Randomized, Cross-over Trial.
Human
community-dwelling older adultsNot specified beyond dietary composition (60% animal protein in omnivorous diet).A Well-Balanced Vegan Diet Does not Compromise Daily Mixed Muscle Protein Synthesis Rates when Compared with an Omnivorous Diet in Active Older Adults: A Randomized Controlled Cross-Over Trial.
Human
female BC survivorsNot specifiedSerum antioxidant capacity, biochemical profile and body composition of breast cancer survivors in a randomized Mediterranean dietary intervention study.
Human
patients prone to developing metabolic syndromeNot specifiedMediterranean Diet Combined with Regular Aerobic Exercise and Hemp Protein Supplementation Modulates Plasma Circulating Amino Acids and Improves the Health Status of Overweight Individuals.
Animal
HSLiKO miceCholesteryl ester accumulation and accelerated cholesterol absorption in intestine-specific hormone sensitive lipase-null mice.
Animal
wild-type C57BL/6J miceNot explicitly stated, but chronic ingestion over 13 weeks.Chronic Intake of Energy Drinks and Their Sugar Free Substitution Similarly Promotes Metabolic Syndrome.
Human
postmenopausal women affected by the metabolic syndrome2 g twice daily (BID).Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study.
Human
obese youth 9-19 y of age with nonalcoholic fatty liver diseaseNot specified (normocaloric diet with n-6:n-3 PUFA ratio of 4:1).A Low ω-6 to ω-3 PUFA Ratio (n-6:n-3 PUFA) Diet to Treat Fatty Liver Disease in Obese Youth.
Human
physically active and healthy menNot specified (isocaloric substitution of animal-based foods with plant-based alternatives).The OMNIVEG STUDY: Health outcomes of shifting from a traditional to a vegan Mediterranean diet in healthy men. A controlled crossover trial.
Human
physically active and healthy menNot specified (isocaloric substitution of animal-based foods with plant-based alternatives).The OMNIVEG STUDY: Health outcomes of shifting from a traditional to a vegan Mediterranean diet in healthy men. A controlled crossover trial.
Animal
obese male and female ratsNot specifiedBeneficial Effects of Dietary Flaxseed on Non-Alcoholic Fatty Liver Disease.
Human
subjects with type 2 diabetesNot specifiedComprehensive analysis of systemic, metabolic, and molecular changes following prospective change to low-carbohydrate diet in adults with type 2 diabetes mellitus in India.
Human
subjects with type 2 diabetesNot specifiedComprehensive analysis of systemic, metabolic, and molecular changes following prospective change to low-carbohydrate diet in adults with type 2 diabetes mellitus in India.
Human
participants with metabolic syndromeNot specified (dietary advice included low-fat dairy as part of the Nordic diet).Analysis of the SYSDIET Healthy Nordic Diet randomized trial based on metabolic profiling reveal beneficial effects on glucose metabolism and blood lipids.
Human
Rotterdam phenotype-A PCOS patientsNot specified (energy-restricted diets with standard vs. low AGE content).Comparison of Metabolic and Hormonal Profiles between Low-Advanced Glycation End Products (AGEs) and Standard AGEs-Containing Weight-Loss Diets in Overweight Phenotype-A PCOS Patients: A Randomized Clinical Trial.
Animal
1% cholesterol addition to dietDietary cholesterol modulates delta6 and delta9 desaturase mRNAs and enzymatic activity in rats fed a low-eFA diet.
Animal
1% cholesterol addition to dietDietary cholesterol modulates delta6 and delta9 desaturase mRNAs and enzymatic activity in rats fed a low-eFA diet.
Human
middle-aged men and women with MetSParticipants consumed 3 MUFA-enriched or PUFA-enriched muffins daily, with additional supplementation to ensure 25%-50% increases in dietary fat intake from these sources.Poly is more effective than monounsaturated fat for dietary management in the metabolic syndrome: The muffin study.
Human
middle-aged men and women with MetSParticipants consumed 3 MUFA-enriched or PUFA-enriched muffins daily, with additional supplementation to ensure 25%-50% increases in dietary fat intake from these sources.Poly is more effective than monounsaturated fat for dietary management in the metabolic syndrome: The muffin study.
Animal
quail0, 1, or 2 g/kg of diet.Use of Maca Powder (Lepidium meyenii) as Feed Additive in Diets of Laying Quails at Different Ages: Its Effect on Performance, Eggshell Quality, Serum, Ileum, and Bone Properties.
Human
men and women with moderate hypercholesterolemiaExperimental diets provided 30% fat, with NuSun sunflower oil contributing half of the total fat (specific dosage not detailed).Balance of unsaturated fatty acids is important to a cholesterol-lowering diet: comparison of mid-oleic sunflower oil and olive oil on cardiovascular disease risk factors.
Human
men and women with moderate hypercholesterolemiaExperimental diets provided 30% fat, with NuSun sunflower oil contributing half of the total fat (specific dosage not detailed).Balance of unsaturated fatty acids is important to a cholesterol-lowering diet: comparison of mid-oleic sunflower oil and olive oil on cardiovascular disease risk factors.
Human
men and women with moderate hypercholesterolemiaExperimental diets provided 30% fat, with NuSun sunflower oil contributing half of the total fat (specific dosage not detailed).Balance of unsaturated fatty acids is important to a cholesterol-lowering diet: comparison of mid-oleic sunflower oil and olive oil on cardiovascular disease risk factors.
Human
type 2 diabetic menNot specified (dietary intervention).Improved plasma glucose control, whole-body glucose utilization, and lipid profile on a low-glycemic index diet in type 2 diabetic men: a randomized controlled trial.
Human
type 2 diabetic menNot specified (dietary intervention).Improved plasma glucose control, whole-body glucose utilization, and lipid profile on a low-glycemic index diet in type 2 diabetic men: a randomized controlled trial.
Human
hypertensive patients who were seeing primary health care providers in a low-income region of BrazilNot specified (monthly planned menus provided).Reductions in glycemic and lipid profiles in hypertensive patients undergoing the Brazilian Dietary Approach to Break Hypertension: a randomized clinical trial.
Human
hypertensive patients who were seeing primary health care providers in a low-income region of BrazilNot specified (monthly planned menus provided).Reductions in glycemic and lipid profiles in hypertensive patients undergoing the Brazilian Dietary Approach to Break Hypertension: a randomized clinical trial.
Animal
male Wistar rats fed a cholesterol-enriched diet (2%)Diet supplemented with 20% of apple cultivars (Bravo de Esmolfe, Malápio Serra, and Golden).Evaluation of cardiovascular protective effect of different apple varieties - Correlation of response with composition.
Animal
male Wistar rats fed a cholesterol-enriched diet (2%)Diet supplemented with 20% of apple cultivars (Bravo de Esmolfe, Malápio Serra, and Golden).Evaluation of cardiovascular protective effect of different apple varieties - Correlation of response with composition.
Human
Men and women aged 35 to 69 years who were nonsmokers with no chronic illness and not on any medicationFat intake constituted 20.3% of total energy in the MUFA diet (specific sunflower oil dosage not detailed).A diet rich in high-oleic-acid sunflower oil favorably alters low-density lipoprotein cholesterol, triglycerides, and factor VII coagulant activity.
Human
overweight young adultsIncreased proportion of saturated fat from <40% to 60% of dietary fat, maintaining total fat, carbohydrate, protein, and calorie intake.Changes in markers for cardio-metabolic disease risk after only 1-2 weeks of a high saturated fat diet in overweight adults.
Human
overweight young adultsIncreased proportion of saturated fat from <40% to 60% of dietary fat, maintaining total fat, carbohydrate, protein, and calorie intake.Changes in markers for cardio-metabolic disease risk after only 1-2 weeks of a high saturated fat diet in overweight adults.
Human
overweight/obese men56 g/day of conventional or high-oleic peanuts.High-oleic peanuts: new perspective to attenuate glucose homeostasis disruption and inflammation related obesity.
Human
Chinese adults with baseline systolic blood pressure 130 to 159 mmHgNot specified (dietary intervention without explicit dosage).Effects of Chinese heart-healthy diet on blood lipids, glucose, and estimated 10-y cardiovascular disease risk among Chinese adults: results on secondary outcomes of a randomized controlled trial.
Human
Chinese adults with baseline systolic blood pressure 130 to 159 mmHgNot specified (dietary intervention without explicit dosage).Effects of Chinese heart-healthy diet on blood lipids, glucose, and estimated 10-y cardiovascular disease risk among Chinese adults: results on secondary outcomes of a randomized controlled trial.
Human
every woman4% carbohydrates, 77% fat, 19% protein (LCHF diet); 44% carbohydrates, 33% fat, 19% protein (control diet)A Ketogenic Low-Carbohydrate High-Fat Diet Increases LDL Cholesterol in Healthy, Young, Normal-Weight Women: A Randomized Controlled Feeding Trial.
Human
healthy, young, and normal-weight women4% carbohydrates, 77% fat, 19% protein (LCHF diet); 44% carbohydrates, 33% fat, 19% protein (control diet)A Ketogenic Low-Carbohydrate High-Fat Diet Increases LDL Cholesterol in Healthy, Young, Normal-Weight Women: A Randomized Controlled Feeding Trial.
Human
forty-seven free-living adultsNot specified (dietary supplementation).Dietary supplementation with chickpeas for at least 5 weeks results in small but significant reductions in serum total and low-density lipoprotein cholesterols in adult women and men.
Human
Not specified (dietary supplementation).Dietary supplementation with chickpeas for at least 5 weeks results in small but significant reductions in serum total and low-density lipoprotein cholesterols in adult women and men.
Human
forty-seven free-living adultsNot specified (dietary supplementation).Dietary supplementation with chickpeas for at least 5 weeks results in small but significant reductions in serum total and low-density lipoprotein cholesterols in adult women and men.
Human
Not specified (dietary supplementation).Dietary supplementation with chickpeas for at least 5 weeks results in small but significant reductions in serum total and low-density lipoprotein cholesterols in adult women and men.
Animal
Thirty-two male Golden Syrian hamsters2.5 g/100 g of dietIndividual trans octadecenoic acids and partially hydrogenated vegetable oil differentially affect hepatic lipid and lipoprotein metabolism in golden Syrian hamsters.
Animal
Thirty-two male Golden Syrian hamsters2.5 g/100 g of dietIndividual trans octadecenoic acids and partially hydrogenated vegetable oil differentially affect hepatic lipid and lipoprotein metabolism in golden Syrian hamsters.
Human
female patients with nonalcoholic fatty liver diseaseNot specifiedImpact of a low-carbohydrate and high-fiber diet on nonalcoholic fatty liver disease.
Human
male patients with nonalcoholic fatty liver diseaseNot specifiedImpact of a low-carbohydrate and high-fiber diet on nonalcoholic fatty liver disease.
Human
patients with acute myocardial infarction (group A)Not specifiedEffect on mortality and reinfarction of adding fruits and vegetables to a prudent diet in the Indian experiment of infarct survival (IEIS).
Human
control groupTwo fasting days of 730 kcal/d (3050 kJ/d) using balanced shakes and dietary supplements, followed by 5 days of habitual diet.Avoiding holiday seasonal weight gain with nutrient-supported intermittent energy restriction: a pilot study.
Human
control groupTwo fasting days of 730 kcal/d (3050 kJ/d) using balanced shakes and dietary supplements, followed by 5 days of habitual diet.Avoiding holiday seasonal weight gain with nutrient-supported intermittent energy restriction: a pilot study.
Human
participants with abnormal baseline valuesNot specifiedChanges in Body Weight, Dysglycemia, and Dyslipidemia After Moderately Low-Carbohydrate Diet Education (LOCABO Challenge Program) Among Workers in Japan.
Human
participants with abnormal baseline valuesNot specifiedChanges in Body Weight, Dysglycemia, and Dyslipidemia After Moderately Low-Carbohydrate Diet Education (LOCABO Challenge Program) Among Workers in Japan.
Human
participants with abnormal baseline valuesNot specifiedChanges in Body Weight, Dysglycemia, and Dyslipidemia After Moderately Low-Carbohydrate Diet Education (LOCABO Challenge Program) Among Workers in Japan.
Human
overweight patients with non-alcoholic fatty liver diseaseDaily administration of Realsil complex (specific dosage not provided).Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease.
Human
overweight patients with non-alcoholic fatty liver diseaseDaily administration of Realsil complex (specific dosage not provided).Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease.
Human
500 mg daily (one capsule)Influence of soy lecithin administration on hypercholesterolemia.
Human
employees who were either overweight (BMI > or = 25 kg/m2) and/or had type 2 diabetesA worksite programme significantly alters nutrient intakes.
Human
patients with non-insulin-dependent diabetes (NIDDM)Not specified (low-fat, vegetarian diet).Toward improved management of NIDDM: A randomized, controlled, pilot intervention using a lowfat, vegetarian diet.
Animal
C57BL/6 J miceNot specified (fast food diet composition not detailed).Partial validation of a six-month high-fat diet and fructose-glucose drink combination as a mouse model of nonalcoholic fatty liver disease.
Animal
male golden hamstersNot specified (described as "high-fat/high-fructose diet").High-fat/high-fructose diet and Opisthorchis viverrini infection promote metabolic dysfunction-associated steatotic liver disease via inflammation, fibrogenesis, and metabolic dysfunction.
Animal
RatsLeucine improves protein nutritional status and regulates hepatic lipid metabolism in calorie-restricted rats.
Human
patients with type 2 diabetes (T2D)Not specifiedA dietary intervention with functional foods reduces metabolic endotoxaemia and attenuates biochemical abnormalities by modifying faecal microbiota in people with type 2 diabetes.
Human
patients with type 2 diabetes (T2D)Not specifiedA dietary intervention with functional foods reduces metabolic endotoxaemia and attenuates biochemical abnormalities by modifying faecal microbiota in people with type 2 diabetes.
Human
28 healthy, non-smoking young men aged between 19 and 31 years12 g sunflower oil/day (as part of a 68 g olive oil + 12 g sunflower oil mixture).Impact of diets containing corn oil or olive/sunflower oil mixture on the human plasma and lipoprotein lipid metabolism.
Human
28 healthy, non-smoking young men aged between 19 and 31 years12 g sunflower oil/day (as part of a 68 g olive oil + 12 g sunflower oil mixture).Impact of diets containing corn oil or olive/sunflower oil mixture on the human plasma and lipoprotein lipid metabolism.
Human
28 healthy, non-smoking young men aged between 19 and 31 years12 g sunflower oil/day (as part of a 68 g olive oil + 12 g sunflower oil mixture).Impact of diets containing corn oil or olive/sunflower oil mixture on the human plasma and lipoprotein lipid metabolism.
Human
28 healthy, non-smoking young men aged between 19 and 31 years12 g sunflower oil/day (as part of a 68 g olive oil + 12 g sunflower oil mixture).Impact of diets containing corn oil or olive/sunflower oil mixture on the human plasma and lipoprotein lipid metabolism.
Human
overweight/obese adultsIER: 30% of energy needs on 2 non-consecutive days/week, 100% on other 5 days; CER: 70% of energy needs daily.Differential effects of intermittent energy restriction vs. continuous energy restriction combined high-intensity interval training on overweight/obese adults: A randomized controlled trial.
Human
overweight/obese adultsIER: 30% of energy needs on 2 non-consecutive days/week, 100% on other 5 days; CER: 70% of energy needs daily.Differential effects of intermittent energy restriction vs. continuous energy restriction combined high-intensity interval training on overweight/obese adults: A randomized controlled trial.
Human
Healthy males (n = 109, mean ± SD age 48 ± 11 y; BMI 25.1 ± 3.3 kg/m2)SFA:UFA as % total energy—19.1:14.8 (higher-SFA/lower-UFA diet) and 8.9:24.5 (lower-SFA/higher-UFA diet).Variation of LDL cholesterol in response to the replacement of saturated with unsaturated fatty acids: a nonrandomized, sequential dietary intervention; the Reading, Imperial, Surrey, Saturated fat Cholesterol Intervention ("RISSCI"-1) study.
Human
Healthy males (n = 109, mean ± SD age 48 ± 11 y; BMI 25.1 ± 3.3 kg/m2)SFA:UFA as % total energy—19.1:14.8 (higher-SFA/lower-UFA diet) and 8.9:24.5 (lower-SFA/higher-UFA diet).Variation of LDL cholesterol in response to the replacement of saturated with unsaturated fatty acids: a nonrandomized, sequential dietary intervention; the Reading, Imperial, Surrey, Saturated fat Cholesterol Intervention ("RISSCI"-1) study.
Human
Healthy males (n = 109, mean ± SD age 48 ± 11 y; BMI 25.1 ± 3.3 kg/m2)SFA:UFA as % total energy—19.1:14.8 (higher-SFA/lower-UFA diet) and 8.9:24.5 (lower-SFA/higher-UFA diet).Variation of LDL cholesterol in response to the replacement of saturated with unsaturated fatty acids: a nonrandomized, sequential dietary intervention; the Reading, Imperial, Surrey, Saturated fat Cholesterol Intervention ("RISSCI"-1) study.
Human
patients with CKD stages 3-4Not specified[Analysis of the Effectiveness of Renoprotection of Low-Protein Diet and Ketoanalogues of Amino Acids In Patients With Chronic Kidney Disease].
Human
adults from high diabetes risk familiesNot specifiedFeel4Diabetes healthy diet score: development and evaluation of clinical validity.
Human
adults from high diabetes risk familiesNot specifiedFeel4Diabetes healthy diet score: development and evaluation of clinical validity.
Human
participants with asthmaNot specifiedA pilot feeding study for adults with asthma: The healthy eating better breathing trial.
Human
subjects55 g low-fiber oat bran, 55 g high-fiber oat bran, or 80 g mixed cooked beans daily.Do beans and oat bran add to the effectiveness of a low-fat diet?
Human
subjects55 g low-fiber oat bran, 55 g high-fiber oat bran, or 80 g mixed cooked beans daily.Do beans and oat bran add to the effectiveness of a low-fat diet?
Human
55 g low-fiber oat bran, 55 g high-fiber oat bran, or 80 g mixed cooked beans daily.Do beans and oat bran add to the effectiveness of a low-fat diet?
Human
subjects in the unrestricted vegan groupAd libitum meat and skim milk consumption (modified DF).Comparison of a Restricted and Unrestricted Vegan Diet Plan with a Restricted Omnivorous Diet Plan on Health-Specific Measures.
Human
American adultsNot specified (DII calculated using 27 dietary components from 24-hour dietary recall)Anti-inflammatory diet reduces risk of metabolic dysfunction-associated fatty liver disease among US adults: a nationwide survey.
Human
both groups60% energy from carbohydrate, 20% from fat (high-carbohydrate diet); 40% energy from carbohydrate, 40% from fat (low-carbohydrate diet).Does a high-carbohydrate diet have different effects in NIDDM patients treated with diet alone or hypoglycemic drugs?
Human
peri or post-menopausal women experiencing vasomotor symptoms160 mg daily (Black Cohosh alone) or 200 mg daily (in multibotanical).The effects of black cohosh therapies on lipids, fibrinogen, glucose and insulin.
Human
peri or post-menopausal women experiencing vasomotor symptoms160 mg daily (Black Cohosh alone) or 200 mg daily (in multibotanical).The effects of black cohosh therapies on lipids, fibrinogen, glucose and insulin.
Human
peri or post-menopausal women experiencing vasomotor symptoms160 mg daily (Black Cohosh alone) or 200 mg daily (in multibotanical).The effects of black cohosh therapies on lipids, fibrinogen, glucose and insulin.
Animal
mice with impaired mitochondrial metabolismOpposing effects of dietary sugar and saturated fat on cardiovascular risk factors and glucose metabolism in mitochondrially impaired mice.
Human
type 2 diabetes (T2D) patientsPositive effects of football on fitness, lipid profile, and insulin resistance in Brazilian patients with type 2 diabetes.
Human
G allele carriers (CG + GG genotypes)Not specifiedDietary-fat effect of the rs10830963 polymorphism in MTNR1B on insulin resistance in response to 3 months weight-loss diets.
Human
no G allele carriers (CC genotype)Not specifiedDietary-fat effect of the rs10830963 polymorphism in MTNR1B on insulin resistance in response to 3 months weight-loss diets.
Human
no G allele carriers (CC genotype)Not specifiedDietary-fat effect of the rs10830963 polymorphism in MTNR1B on insulin resistance in response to 3 months weight-loss diets.
Human
G allele carriers (CG + GG genotypes)Not specifiedDietary-fat effect of the rs10830963 polymorphism in MTNR1B on insulin resistance in response to 3 months weight-loss diets.
Human
postmenopausal women30 g of soy protein and 4 g of phytosterols per day.Effect of a low glycemic index diet with soy protein and phytosterols on CVD risk factors in postmenopausal women.
Human
postmenopausal women30 g of soy protein and 4 g of phytosterols per day.Effect of a low glycemic index diet with soy protein and phytosterols on CVD risk factors in postmenopausal women.
Human
postmenopausal women30 g of soy protein and 4 g of phytosterols per day.Effect of a low glycemic index diet with soy protein and phytosterols on CVD risk factors in postmenopausal women.
Human
postmenopausal women30 g of soy protein and 4 g of phytosterols per day.Effect of a low glycemic index diet with soy protein and phytosterols on CVD risk factors in postmenopausal women.
Animal
hypercholesterolemic ratsHypocholesterolemic Effects of the Cauliflower Culinary-Medicinal Mushroom, Sparassis crispa (Higher Basidiomycetes), in Diet-Induced Hypercholesterolemic Rats.
Human
both groups10 mg monacolin K daily (one tablet per day).The short-term supplementation of monacolin K improves the lipid and metabolic patterns of hypertensive and hypercholesterolemic subjects at low cardiovascular risk.
Human
subjects with grade-1 essential hypertension10 mg monacolin K daily (one tablet per day).The short-term supplementation of monacolin K improves the lipid and metabolic patterns of hypertensive and hypercholesterolemic subjects at low cardiovascular risk.
Human
women with polycystic ovary syndrome (PCOS)Not specified (part of a pulse-based diet including lentils, beans, split peas, and chickpeas).A Comparison of a Pulse-Based Diet and the Therapeutic Lifestyle Changes Diet in Combination with Exercise and Health Counselling on the Cardio-Metabolic Risk Profile in Women with Polycystic Ovary Syndrome: A Randomized Controlled Trial.
Human
women with polycystic ovary syndrome (PCOS)Not specified (part of a pulse-based diet including lentils, beans, split peas, and chickpeas).A Comparison of a Pulse-Based Diet and the Therapeutic Lifestyle Changes Diet in Combination with Exercise and Health Counselling on the Cardio-Metabolic Risk Profile in Women with Polycystic Ovary Syndrome: A Randomized Controlled Trial.
Animal
fruit fliesNovel ketogenic diet formulation improves sucrose-induced insulin resistance in canton strain Drosophila melanogaster.
Human
middle-aged adults with obesityNot specifiedEffects of Combined High-Protein Diet and Exercise Intervention on Cardiometabolic Health in Middle-Aged Obese Adults: A Randomized Controlled Trial.
Human
Q1 and Q4 participantsNot specifiedChange to a healthy diet in people over 70 years old: the PREDIMED experience.
Human
overweight men and women40 g milk fat/day as either whipping cream or butter oil.Potential role of milk fat globule membrane in modulating plasma lipoproteins, gene expression, and cholesterol metabolism in humans: a randomized study.
Human
overweight men and women40 g milk fat/day as either whipping cream or butter oil.Potential role of milk fat globule membrane in modulating plasma lipoproteins, gene expression, and cholesterol metabolism in humans: a randomized study.
Human
overweight men and women40 g milk fat/day as either whipping cream or butter oil.Potential role of milk fat globule membrane in modulating plasma lipoproteins, gene expression, and cholesterol metabolism in humans: a randomized study.
Human
overweight men and women40 g milk fat/day as either whipping cream or butter oil.Potential role of milk fat globule membrane in modulating plasma lipoproteins, gene expression, and cholesterol metabolism in humans: a randomized study.
Human
overweight men and women40 g milk fat/day as either whipping cream or butter oil.Potential role of milk fat globule membrane in modulating plasma lipoproteins, gene expression, and cholesterol metabolism in humans: a randomized study.
Human
overweight men and women40 g milk fat/day as either whipping cream or butter oil.Potential role of milk fat globule membrane in modulating plasma lipoproteins, gene expression, and cholesterol metabolism in humans: a randomized study.
Human
overweight men and women40 g milk fat/day as either whipping cream or butter oil.Potential role of milk fat globule membrane in modulating plasma lipoproteins, gene expression, and cholesterol metabolism in humans: a randomized study.
Human
patients with type 2 diabetic nephropathy (T2DN)35% and 100% SP diets (percentage of total protein intake).Comparison of the effects of different percentages of soy protein in the diet on patients with type 2 diabetic nephropathy: systematic reviews and network meta-analysis.
Human
patients with type 2 diabetic nephropathy (T2DN)35% and 100% SP diets (percentage of total protein intake).Comparison of the effects of different percentages of soy protein in the diet on patients with type 2 diabetic nephropathy: systematic reviews and network meta-analysis.
Human
patients with type 2 diabetic nephropathy (T2DN)35% and 100% SP diets (percentage of total protein intake).Comparison of the effects of different percentages of soy protein in the diet on patients with type 2 diabetic nephropathy: systematic reviews and network meta-analysis.
Human
33 Chinese T2DM patients~60g/d of almonds.Almonds ameliorate glycemic control in Chinese patients with better controlled type 2 diabetes: a randomized, crossover, controlled feeding trial.
Animal
hypercholesterolemic rat model6.5-7.5% of the dietBarley beta-glucans varying in molecular mass and oligomer structure affect cecal fermentation and microbial composition but not blood lipid profiles in hypercholesterolemic rats.
Human
adults with overweight or obesityNot specified.Changes in bile acid subtypes and improvements in lipid metabolism and atherosclerotic cardiovascular disease risk: the Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost) trial.
Human
human participantsNot specified.Current evidence on the health-beneficial effects of berry fruits in the prevention and treatment of metabolic syndrome.
Human
human participantsNot specified.Current evidence on the health-beneficial effects of berry fruits in the prevention and treatment of metabolic syndrome.
Human
overweight dogsBody weight-dependent amount (specific dosage not detailed)Effect of a weight loss diet with or without Spirulina supplementation on serum lipids and antioxidant capacity of overweight dogs.
Human
mildly hypercholesterolemic menNot specified in the abstract.Beta-glucan- or rice bran-enriched foods: a comparative crossover clinical trial on lipidic pattern in mildly hypercholesterolemic men.
Human
mildly hypercholesterolemic menNot specified in the abstract.Beta-glucan- or rice bran-enriched foods: a comparative crossover clinical trial on lipidic pattern in mildly hypercholesterolemic men.
Human
mildly hypercholesterolemic menNot specified in the abstract.Beta-glucan- or rice bran-enriched foods: a comparative crossover clinical trial on lipidic pattern in mildly hypercholesterolemic men.
Human
mildly hypercholesterolemic menNot specified in the abstract.Beta-glucan- or rice bran-enriched foods: a comparative crossover clinical trial on lipidic pattern in mildly hypercholesterolemic men.
Human
subjects with IRH20 g of fibre (fructose-oligosaccharides) per day.Idiopathic reactive hypoglycaemia - prevalence and effect of fibre on glucose excursions.
Human
healthy premenopausal womenApproximately 10% of energy from fat.Effectiveness of a low-fat vegetarian diet in altering serum lipids in healthy premenopausal women.
Human
premenopausal womenApproximately 10% of energy from fat.Effectiveness of a low-fat vegetarian diet in altering serum lipids in healthy premenopausal women.
Human
healthy premenopausal womenApproximately 10% of energy from fat.Effectiveness of a low-fat vegetarian diet in altering serum lipids in healthy premenopausal women.
Human
premenopausal womenApproximately 10% of energy from fat.Effectiveness of a low-fat vegetarian diet in altering serum lipids in healthy premenopausal women.
Human
healthy premenopausal womenApproximately 10% of energy from fat.Effectiveness of a low-fat vegetarian diet in altering serum lipids in healthy premenopausal women.
Human
premenopausal womenApproximately 10% of energy from fat.Effectiveness of a low-fat vegetarian diet in altering serum lipids in healthy premenopausal women.
Human
patients with MSNot specifiedEffectiveness of DASH Diet versus Other Diet Modalities in Patients with Metabolic Syndrome: A Systematic Review and Meta-Analysis.
Human
patients with MSNot specifiedEffectiveness of DASH Diet versus Other Diet Modalities in Patients with Metabolic Syndrome: A Systematic Review and Meta-Analysis.
Human
Not specifiedPractical dietary interventions to prevent cardiovascular disease suitable for implementation in primary care: an ADAPTE-guided systematic review of international clinical guidelines.
Human
subjects with MetSNot specifiedThe effect of dietary approaches to stop hypertension (DASH) diet on fatty liver and cardiovascular risk factors in subjects with metabolic syndrome: a randomized controlled trial.
Human
subjects with MetSNot specifiedThe effect of dietary approaches to stop hypertension (DASH) diet on fatty liver and cardiovascular risk factors in subjects with metabolic syndrome: a randomized controlled trial.
Human
adults from 27 counties of Khuzestan province, IranNot specifiedThe Association between DASH Diet Adherence and Cardiovascular Risk Factors.
Human
adults from 27 counties of Khuzestan province, IranNot specifiedThe Association between DASH Diet Adherence and Cardiovascular Risk Factors.
Human
patients on corticosteroid therapyNot specified (dietary intake followed DASH guidelines).Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on the Metabolic Side Effects of Corticosteroid Medications.
Human
overweight and obese patients with NAFLDNot specified (dietary pattern, not isolated dairy intake).The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial.
Human
overweight and obese women with polycystic ovary syndrome (PCOS)Not specified (diet composition: 52% carbohydrates, 18% proteins, 30% total fats, with DASH emphasizing fruits, vegetables, whole grains, and low-fat dairy).Effects of DASH diet on lipid profiles and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized clinical trial.
Human
overweight and obese women with polycystic ovary syndrome (PCOS)Not specified (diet composition: 52% carbohydrates, 18% proteins, 30% total fats, with DASH emphasizing fruits, vegetables, whole grains, and low-fat dairy).Effects of DASH diet on lipid profiles and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized clinical trial.
Human
healthy omnivore subjectsNot specified (unsupplemented vegan diet)Vitamin B12 Status Upon Short-Term Intervention with a Vegan Diet-A Randomized Controlled Trial in Healthy Participants.
Animal
juvenile common carp (Cyprinus carpio)0.16% MCS supplementation in the 28%P/46%C diet.Momordica charantia saponins administration in low-protein-high-carbohydrate diet improves growth, blood biochemical, intestinal health and microflora composition of juvenile common carp (Cyprinus carpio).
Animal
juvenile common carp (Cyprinus carpio)0.16% MCS supplementation in the 28%P/46%C diet.Momordica charantia saponins administration in low-protein-high-carbohydrate diet improves growth, blood biochemical, intestinal health and microflora composition of juvenile common carp (Cyprinus carpio).
Human
obese subjectsNot specifiedImpact of 2 Different Hypocaloric Diets on Serum Omentin Levels in Obese Subjects.
Human
obese subjectsNot specifiedImpact of 2 Different Hypocaloric Diets on Serum Omentin Levels in Obese Subjects.
Human
adults without known cardiovascular disease (CVD) risk factorsNot specifiedBehavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Human
adultsDiet recommendations: saturated/trans fat intake <10% of total calories, cholesterol <300 mg/day, fiber ≥25 g/day (women) or ≥35 g/day (men).Efficacy of aerobic exercise and a prudent diet for improving selected lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials.
Human
adultsDiet recommendations: saturated/trans fat intake <10% of total calories, cholesterol <300 mg/day, fiber ≥25 g/day (women) or ≥35 g/day (men).Efficacy of aerobic exercise and a prudent diet for improving selected lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials.
Human
adultsDiet recommendations: saturated/trans fat intake <10% of total calories, cholesterol <300 mg/day, fiber ≥25 g/day (women) or ≥35 g/day (men).Efficacy of aerobic exercise and a prudent diet for improving selected lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials.
Human
adultsDiet recommendations: saturated/trans fat intake <10% of total calories, cholesterol <300 mg/day, fiber ≥25 g/day (women) or ≥35 g/day (men).Efficacy of aerobic exercise and a prudent diet for improving selected lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials.
Human
adultsDiet recommendations: saturated/trans fat intake <10% of total calories, cholesterol <300 mg/day, fiber ≥25 g/day (women) or ≥35 g/day (men).Efficacy of aerobic exercise and a prudent diet for improving selected lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials.
Human
individuals with insulin-treated type 2 diabetesAd libitum, meals provided (specific amounts not detailed).The acute effects of a DASH diet and whole food, plant-based diet on insulin requirements and related cardiometabolic markers in individuals with insulin-treated type 2 diabetes.
Human
individuals with insulin-treated type 2 diabetesAd libitum, meals provided (specific amounts not detailed).The acute effects of a DASH diet and whole food, plant-based diet on insulin requirements and related cardiometabolic markers in individuals with insulin-treated type 2 diabetes.
Human
individuals with insulin-treated type 2 diabetesAd libitum, meals provided (specific amounts not detailed).The acute effects of a DASH diet and whole food, plant-based diet on insulin requirements and related cardiometabolic markers in individuals with insulin-treated type 2 diabetes.
Human
overweight adultsFour diets varying in glycemic index (40% or 65%) and carbohydrate content (40% or 58% of energy).Effects of high vs low glycemic index of dietary carbohydrate on cardiovascular disease risk factors and insulin sensitivity: the OmniCarb randomized clinical trial.
Human
overweight adultsFour diets varying in glycemic index (40% or 65%) and carbohydrate content (40% or 58% of energy).Effects of high vs low glycemic index of dietary carbohydrate on cardiovascular disease risk factors and insulin sensitivity: the OmniCarb randomized clinical trial.
Human
people with NAFLD250 mg of beetroot juice.Comparing effects of beetroot juice and Mediterranean diet on liver enzymes and sonographic appearance in patients with non-alcoholic fatty liver disease: a randomized control trials.
Human
people with NAFLD250 mg of beetroot juice.Comparing effects of beetroot juice and Mediterranean diet on liver enzymes and sonographic appearance in patients with non-alcoholic fatty liver disease: a randomized control trials.
Human
patients with Acute Coronary Syndromes (ACS)An organic khorasan wheat-based replacement diet improves risk profile of patients with acute coronary syndrome: a randomized crossover trial.
Human
patients with Acute Coronary Syndromes (ACS)An organic khorasan wheat-based replacement diet improves risk profile of patients with acute coronary syndrome: a randomized crossover trial.
Animal
male, albino Wistar rats fed an atherogenic diet for 45 days and treated with salineEvaluation of the anti-atherogenic potential of chrysin in Wistar rats.
Animal
Sprague-Dawley ratsAn atherogenic diet decreases liver FXR gene expression and causes severe hepatic steatosis and hepatic cholesterol accumulation: effect of endurance training.
Animal
Sprague-Dawley ratsAn atherogenic diet decreases liver FXR gene expression and causes severe hepatic steatosis and hepatic cholesterol accumulation: effect of endurance training.
Human
MetS patients1.24 g/d of long-chain (n-3) PUFA or placebo (1.24 g/d of high-oleic sunflower-seed oil).A low-fat, high-complex carbohydrate diet supplemented with long-chain (n-3) fatty acids alters the postprandial lipoprotein profile in patients with metabolic syndrome.
Human
Subjects with the metabolic syndromeNot specifiedA new dietary strategy for long-term treatment of the metabolic syndrome is compared with the American Heart Association (AHA) guidelines: the MEtabolic Syndrome REduction in NAvarra (RESMENA) project.
Human
Subjects with the metabolic syndromeNot specifiedA new dietary strategy for long-term treatment of the metabolic syndrome is compared with the American Heart Association (AHA) guidelines: the MEtabolic Syndrome REduction in NAvarra (RESMENA) project.
Human
Not specifiedCholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases.
Human
Twenty-five hyperlipidemic subjects16.6 g of almonds per 1,000 kcalThe effect of combining plant sterols, soy protein, viscous fibers, and almonds in treating hypercholesterolemia.
Human
Chinese females with NAFLDNot specified for fiber alone.Effect of an Asian-adapted Mediterranean diet and pentadecanoic acid on fatty liver disease: the TANGO randomized controlled trial.
Human
Not specifiedIntermittent fasting for weight management and metabolic health: An updated comprehensive umbrella review of health outcomes.
Human
overweight and obese individualsNot specified (5:2 diet protocol—2 fasting days per week).Effect of the 5:2 Diet on Weight Loss and Cardiovascular Disease Risk Factors in Overweight and/or Obesity: A Systematic Review and Meta-Analysis.
Human
children and adolescents with obesityNot specified (diet composition: 60% carbohydrate, 25% fat, 15% protein, rich in polyunsaturated fatty acids, fiber, flavonoids, and antioxidants).Mediterranean-style diet reduces metabolic syndrome components in obese children and adolescents with obesity.
Animal
Arabi male lambsNot specifiedUse of tannase-producing bacteria isolated from the rumen to improve the nutritional value of pomegranate peel for fattening lambs.
Human
patients with MetS30 g/day of mixed nuts (15 g walnuts, 7.5 g almonds, 7.5 g hazelnuts).Effects of one serving of mixed nuts on serum lipids, insulin resistance and inflammatory markers in patients with the metabolic syndrome.
Human
patients aged 40 to 80 years and diagnosed with CADGroup 1: 30 g/day of pecan nuts; Group 2: 30 ml/day of olive oil; Group 3: control diet.Effect of polymorphisms in the CD36 and STAT3 genes on different dietary interventions among patients with coronary artery disease: study protocol for a randomized controlled trial.
Human
adults (≥18 years) with dyslipidemia (not undergoing pharmacological treatment)Not specifiedIntervention design and adherence to Mediterranean diet in the Cardiovascular Risk Prevention with a Mediterranean Dietary Pattern Reduced in Saturated Fat (CADIMED) randomized trial.
Human
adults (≥18 years) with dyslipidemia (not undergoing pharmacological treatment)Not specifiedIntervention design and adherence to Mediterranean diet in the Cardiovascular Risk Prevention with a Mediterranean Dietary Pattern Reduced in Saturated Fat (CADIMED) randomized trial.
Human
hypercholesterolemic subjectsNot specified for beta-carotene (PS dosage: 2 g/day)Evaluation of cardiovascular risk and oxidative stress parameters in hypercholesterolemic subjects on a standard healthy diet including low-fat milk enriched with plant sterols.
Human
hypercholesterolemic subjectsNot specified for beta-carotene (PS dosage: 2 g/day)Evaluation of cardiovascular risk and oxidative stress parameters in hypercholesterolemic subjects on a standard healthy diet including low-fat milk enriched with plant sterols.
Human
hypercholesterolemic subjectsNot specified for beta-carotene (PS dosage: 2 g/day)Evaluation of cardiovascular risk and oxidative stress parameters in hypercholesterolemic subjects on a standard healthy diet including low-fat milk enriched with plant sterols.
Human
people with metabolic syndromeLow-fat dairy products included as part of the diet (specific amounts not detailed).Effects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndrome -- a randomized study (SYSDIET).
Human
people with metabolic syndromeLow-fat dairy products included as part of the diet (specific amounts not detailed).Effects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndrome -- a randomized study (SYSDIET).
Human
subjects from the SU.VI.MAX studyNot specified (adherence assessed via dietary scores from at least three 24-hour records).Adherence to Mediterranean diet reduces the risk of metabolic syndrome: a 6-year prospective study.
Human
subjects from the SU.VI.MAX studyNot specified (adherence assessed via dietary scores from at least three 24-hour records).Adherence to Mediterranean diet reduces the risk of metabolic syndrome: a 6-year prospective study.
Human
Australian patients post coronary eventAd libitum (no specific dosage provided).Ad libitum Mediterranean diet reduces subcutaneous but not visceral fat in patients with coronary heart disease: A randomised controlled pilot study.
Human
Australian patients post coronary eventAd libitum (no specific dosage provided).Ad libitum Mediterranean diet reduces subcutaneous but not visceral fat in patients with coronary heart disease: A randomised controlled pilot study.
Human
overweight or obese US adultsNot specifiedPilot randomized controlled trial of a Mediterranean diet or diet supplemented with fish oil, walnuts, and grape juice in overweight or obese US adults.
Human
overweight or obese US adultsNot specifiedPilot randomized controlled trial of a Mediterranean diet or diet supplemented with fish oil, walnuts, and grape juice in overweight or obese US adults.
Human
subjects in the Mediterranean Diet groupNot specified (dietary intervention)Mediterranean diet effects on vascular health and serum levels of adipokines and ceramides.
Human
subjects in the Mediterranean Diet groupNot specified (dietary intervention)Mediterranean diet effects on vascular health and serum levels of adipokines and ceramides.
Human
subjects in the Mediterranean Diet groupNot specified (dietary intervention)Mediterranean diet effects on vascular health and serum levels of adipokines and ceramides.
Human
Not specifiedDoes the Mediterranean Diet Play a Beneficial Role in Managing the Health of Overweight/Obese Breast Cancer Survivors?
Human
overweight healthy women aged 20-40 yNot specified (test foods replaced usual carbohydrate-rich foods, matched for energy, density, fiber, and macronutrients).No difference in body weight decrease between a low-glycemic-index and a high-glycemic-index diet but reduced LDL cholesterol after 10-wk ad libitum intake of the low-glycemic-index diet.
Human
overweight healthy women aged 20-40 yNot specified (test foods replaced usual carbohydrate-rich foods, matched for energy, density, fiber, and macronutrients).No difference in body weight decrease between a low-glycemic-index and a high-glycemic-index diet but reduced LDL cholesterol after 10-wk ad libitum intake of the low-glycemic-index diet.
Human
overweight healthy women aged 20-40 yNot specified (test foods replaced usual carbohydrate-rich foods, matched for energy, density, fiber, and macronutrients).No difference in body weight decrease between a low-glycemic-index and a high-glycemic-index diet but reduced LDL cholesterol after 10-wk ad libitum intake of the low-glycemic-index diet.
Human
30 patients with type II diabetes, 6 weeks post bypass surgeryLow fat, 8 g/1000 kcal viscous fibres, 17 g/1000 kcal soy protein, and 22 g/1000 kcal almonds.A modified portfolio diet complements medical management to reduce cardiovascular risk factors in diabetic patients with coronary artery disease.
Human
adults with NAFLDAt least 4 servings of fruits daily (FRD group) vs. less than 2 servings/day (control group).The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
Human
obese men with obstructive sleep apneaNot specifiedOne-month of a low-energy diet, with no additional effect of high-protein, reduces Obstructive Sleep Apnea severity and improve metabolic parameters in obese males.
Human
patients with hypercholesterolemiaNot specifiedEffects of phytosterol supplementation on lipid profiles in patients with hypercholesterolemia: a systematic review and meta-analysis of randomized controlled trials.
Human
patients with hypercholesterolemiaNot specifiedEffects of phytosterol supplementation on lipid profiles in patients with hypercholesterolemia: a systematic review and meta-analysis of randomized controlled trials.
Human
Individuals with type 2 diabetesNot specified (dietary intervention).A low-fat vegan diet elicits greater macronutrient changes, but is comparable in adherence and acceptability, compared with a more conventional diabetes diet among individuals with type 2 diabetes.
Human
10 patients with non-insulin-dependent diabetes mellitus (NIDDM) receiving insulin therapyHigh-carbohydrate diet: 60% carbohydrates (47% complex carbohydrates), 25% fat.Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus.
Human
10 patients with non-insulin-dependent diabetes mellitus (NIDDM) receiving insulin therapyHigh-carbohydrate diet: 60% carbohydrates (47% complex carbohydrates), 25% fat.Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus.
Human
10 patients with non-insulin-dependent diabetes mellitus (NIDDM) receiving insulin therapyHigh-carbohydrate diet: 60% carbohydrates (47% complex carbohydrates), 25% fat.Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus.
Human
10 patients with non-insulin-dependent diabetes mellitus (NIDDM) receiving insulin therapyHigh-carbohydrate diet: 60% carbohydrates (47% complex carbohydrates), 25% fat.Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus.
Human
people with type 1 diabetes17% to 20% of total daily calories from monounsaturated fat.Impact of a high-monounsaturated-fat diet on lipid profile in subjects with type 1 diabetes.
Human
people with type 1 diabetes17% to 20% of total daily calories from monounsaturated fat.Impact of a high-monounsaturated-fat diet on lipid profile in subjects with type 1 diabetes.
Human
healthy participantsTest fats contributed 20% of total energy intake (33% total fat).Eucaloric diets enriched in palm olein, cocoa butter, and soybean oil did not differentially affect liver fat concentration in healthy participants: a 16-week randomized controlled trial.
Human
healthy participantsTest fats contributed 20% of total energy intake (33% total fat).Eucaloric diets enriched in palm olein, cocoa butter, and soybean oil did not differentially affect liver fat concentration in healthy participants: a 16-week randomized controlled trial.
Human
healthy participantsTest fats contributed 20% of total energy intake (33% total fat).Eucaloric diets enriched in palm olein, cocoa butter, and soybean oil did not differentially affect liver fat concentration in healthy participants: a 16-week randomized controlled trial.
Animal
Sprague-Dawley ratsImpact of protein intake from a caloric-restricted diet on liver lipid metabolism in overweight and obese rats of different sexes.
Human
previously non-vegetarian subjects from a Mediterranean populationA whole lacto-vegetarian diet low in fat (20%) was provided as a full daily menu.[SHORT TERM EFFECTS ON LIPID PROFILE AND GLYCAEMIA OF A LOW-FAT VEGETARIAN DIET].
Human
A whole lacto-vegetarian diet low in fat (20%) was provided as a full daily menu.[SHORT TERM EFFECTS ON LIPID PROFILE AND GLYCAEMIA OF A LOW-FAT VEGETARIAN DIET].
Human
34 male overweight subjects; aged between 25 and 65 years who were overall healthy apart from overweightNot specifiedEffects of n-3 polyunsaturated fatty acids (ω-3) supplementation on some cardiovascular risk factors with a ketogenic Mediterranean diet.
Animal
Male Wistar ratsNot specifiedEffect of a multivitamin preparation supplemented with phytosterol on serum lipids and infarct size in rats fed with normal and high cholesterol diet.
Human
patients with NAFLDA Khorasan Wheat-Based Replacement Diet Improves Risk Profile of Patients With Nonalcoholic Fatty Liver Disease (NAFLD): A Randomized Clinical Trial.
Human
overweight/obese participants with type 2 diabetesNot specifiedOne-year comparison of a high-monounsaturated fat diet with a high-carbohydrate diet in type 2 diabetes.
Human
Kurdish adults between the ages of 39 and 53Not specifiedAssociations between adherence to MIND diet and general obesity and lipid profile: A cross-sectional study.
Human
Iranian adultsNot specifiedAssociations between adherence to MIND diet and metabolic syndrome and general and abdominal obesity: a cross-sectional study.
Human
18 fibromyalgia patientsNot specified (strict, low-salt, uncooked vegan diet).Vegan diet alleviates fibromyalgia symptoms.
Human
Healthy, obese adultsHigh-fat diet: ≤20 g carbohydrates/day; high-carb diet: 55% of total energy intake from carbohydrates.Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate diet.
Human
Healthy, obese adultsHigh-fat diet: ≤20 g carbohydrates/day; high-carb diet: 55% of total energy intake from carbohydrates.Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate diet.
Human
Healthy, obese adultsHigh-fat diet: ≤20 g carbohydrates/day; high-carb diet: 55% of total energy intake from carbohydrates.Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate diet.
Human
HIV-infected antiretroviral-naive patientsNot specifiedEffects of Spirulina platensis supplementation on lipid profile in HIV-infected antiretroviral naïve patients in Yaounde-Cameroon: a randomized trial study.
Human
HIV-infected antiretroviral-naive patientsNot specifiedEffects of Spirulina platensis supplementation on lipid profile in HIV-infected antiretroviral naïve patients in Yaounde-Cameroon: a randomized trial study.
Human
HIV-infected antiretroviral-naive patientsNot specifiedEffects of Spirulina platensis supplementation on lipid profile in HIV-infected antiretroviral naïve patients in Yaounde-Cameroon: a randomized trial study.
Human
obese subjects4 weekly servings (160-235 g per serving) of lentils, chickpeas, peas, or beans.A legume-based hypocaloric diet reduces proinflammatory status and improves metabolic features in overweight/obese subjects.
Human
obese subjects4 weekly servings (160-235 g per serving) of lentils, chickpeas, peas, or beans.A legume-based hypocaloric diet reduces proinflammatory status and improves metabolic features in overweight/obese subjects.
Human
individuals with metabolic syndrome (MetS)Two eggs per day (or equivalent egg substitute) with 70 g of spinach for breakfast.Eggs Improve Plasma Biomarkers in Patients with Metabolic Syndrome Following a Plant-Based Diet-A Randomized Crossover Study.
Human
at-risk New Zealand Defence Force personnelNot specified.A 12-week low-carbohydrate, high-fat diet improves metabolic health outcomes over a control diet in a randomised controlled trial with overweight defence force personnel.
Human
at-risk New Zealand Defence Force personnelNot specified.A 12-week low-carbohydrate, high-fat diet improves metabolic health outcomes over a control diet in a randomised controlled trial with overweight defence force personnel.
Human
at-risk New Zealand Defence Force personnelNot specified.A 12-week low-carbohydrate, high-fat diet improves metabolic health outcomes over a control diet in a randomised controlled trial with overweight defence force personnel.
Human
participants with T2DMHCLF diet with 50-60% carbohydrates, 20-30% fats, and 20-25% proteins.Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease : A Randomized Controlled Trial.
Human
participants with T2DMHCLF diet with 50-60% carbohydrates, 20-30% fats, and 20-25% proteins.Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease : A Randomized Controlled Trial.
Human
A-allele carriersNot specified[Influence of rs670 variant of APOA1 gene on serum HDL response to an enriched-polyunsaturated vs. an enriched-monounsaturated fat hypocaloric diet].
Human
A-allele carriersNot specified[Influence of rs670 variant of APOA1 gene on serum HDL response to an enriched-polyunsaturated vs. an enriched-monounsaturated fat hypocaloric diet].
Human
obese NAFLD patientsThree 1000 mg softgels of CLA daily, alongside a weight loss diet and 400 IU vitamin E.Conjugated linoleic acid improves glycemic response, lipid profile, and oxidative stress in obese patients with non-alcoholic fatty liver disease: a randomized controlled clinical trial.
Human
obese middle-aged individuals20 mg/dLutein supplementation combined with a low-calorie diet in middle-aged obese individuals: effects on anthropometric indices, body composition and metabolic parameters.
Human
obese middle-aged individuals20 mg/dLutein supplementation combined with a low-calorie diet in middle-aged obese individuals: effects on anthropometric indices, body composition and metabolic parameters.
Human
obese middle-aged individuals20 mg/dLutein supplementation combined with a low-calorie diet in middle-aged obese individuals: effects on anthropometric indices, body composition and metabolic parameters.
Human
141 middle-aged adultsNot specifiedThe Association Between Diet and Cardio-Metabolic Risk on Cognitive Performance: A Cross-Sectional Study of Middle-Aged Australian Adults.
Animal
chick offspringSupplementing conjugated linoleic acid in breeder hens diet increased conjugated linoleic acid incorporation in liver and alters hepatic lipid metabolism in chick offspring.
Human
forty-six overweight women (50-72 years, BMI 25-33 kg/m² and normal fasting glycaemia)82 g/d chickpeas (as part of D1).Combining functional features of whole-grain barley and legumes for dietary reduction of cardiometabolic risk: a randomised cross-over intervention in mature women.
Human
forty-six overweight women (50-72 years, BMI 25-33 kg/m² and normal fasting glycaemia)82 g/d chickpeas (as part of D1).Combining functional features of whole-grain barley and legumes for dietary reduction of cardiometabolic risk: a randomised cross-over intervention in mature women.
Human
forty-six overweight women (50-72 years, BMI 25-33 kg/m² and normal fasting glycaemia)82 g/d chickpeas (as part of D1).Combining functional features of whole-grain barley and legumes for dietary reduction of cardiometabolic risk: a randomised cross-over intervention in mature women.
Human
forty-six overweight women (50-72 years, BMI 25-33 kg/m² and normal fasting glycaemia)82 g/d chickpeas (as part of D1).Combining functional features of whole-grain barley and legumes for dietary reduction of cardiometabolic risk: a randomised cross-over intervention in mature women.
Human
forty-six overweight women (50-72 years, BMI 25-33 kg/m² and normal fasting glycaemia)82 g/d chickpeas (as part of D1).Combining functional features of whole-grain barley and legumes for dietary reduction of cardiometabolic risk: a randomised cross-over intervention in mature women.
Human
overweight/obese Chinese femalesNot specifiedNon-Energy-Restricted Low-Carbohydrate Diet Combined with Exercise Intervention Improved Cardiometabolic Health in Overweight Chinese Females.
Human
overweight/obese Chinese femalesNot specifiedNon-Energy-Restricted Low-Carbohydrate Diet Combined with Exercise Intervention Improved Cardiometabolic Health in Overweight Chinese Females.
Human
overweight/obese Chinese femalesNot specifiedNon-Energy-Restricted Low-Carbohydrate Diet Combined with Exercise Intervention Improved Cardiometabolic Health in Overweight Chinese Females.
Human
adults with type 2 diabetesNot specified (varied by study).The interpretation and effect of a low-carbohydrate diet in the management of type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials.
Human
148 men and women without clinical cardiovascular disease and diabetesLow-carbohydrate (<40 g/d) or low-fat (<30% of daily energy intake from total fat, <7% saturated fat).Effects of low-carbohydrate and low-fat diets: a randomized trial.
Human
148 men and women without clinical cardiovascular disease and diabetesLow-carbohydrate (<40 g/d) or low-fat (<30% of daily energy intake from total fat, <7% saturated fat).Effects of low-carbohydrate and low-fat diets: a randomized trial.
Human
1,141 obese patientsNot specifiedSystematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors.
Human
1,141 obese patientsNot specifiedSystematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors.
Human
adolescents with overweight and obesityNot specifiedLow-Carbohydrate Diet is More Helpful for Weight Loss Than Low-Fat Diet in Adolescents with Overweight and Obesity: A Systematic Review and Meta-Analysis.
Human
adolescents with overweight and obesityNot specifiedLow-Carbohydrate Diet is More Helpful for Weight Loss Than Low-Fat Diet in Adolescents with Overweight and Obesity: A Systematic Review and Meta-Analysis.
Human
adolescents with overweight and obesityNot specifiedLow-Carbohydrate Diet is More Helpful for Weight Loss Than Low-Fat Diet in Adolescents with Overweight and Obesity: A Systematic Review and Meta-Analysis.
Human
persons with obesity<40% energy from carbohydrates (low-carbohydrate diet), <30% energy from fat (low-fat diet)Effects of macronutrient intake in obesity: a meta-analysis of low-carbohydrate and low-fat diets on markers of the metabolic syndrome.
Human
307 participants with a mean age of 45.5 years and mean body mass index of 36.1 kg/m(2)1200 to 1800 kcal/day, ≤30% calories from fat.Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial.
Human
307 participants with a mean age of 45.5 years and mean body mass index of 36.1 kg/m(2)1200 to 1800 kcal/day, ≤30% calories from fat.Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial.
Human
307 participants with a mean age of 45.5 years and mean body mass index of 36.1 kg/m(2)1200 to 1800 kcal/day, ≤30% calories from fat.Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial.
Human
trials with mean baseline BMI <25<130 g/d carbohydrateIncreased low-density lipoprotein cholesterol on a low-carbohydrate diet in adults with normal but not high body weight: A meta-analysis.
Human
trials with a mean of BMI 25-<35<130 g/d carbohydrateIncreased low-density lipoprotein cholesterol on a low-carbohydrate diet in adults with normal but not high body weight: A meta-analysis.
Human
trials with a mean BMI ≥35<130 g/d carbohydrateIncreased low-density lipoprotein cholesterol on a low-carbohydrate diet in adults with normal but not high body weight: A meta-analysis.
Human
participants in randomized controlled trials<130 g/d carbohydrateIncreased low-density lipoprotein cholesterol on a low-carbohydrate diet in adults with normal but not high body weight: A meta-analysis.
Human
patients with type 2 diabetesNot AssessedThe use of low-carbohydrate diet in type 2 diabetes - benefits and risks.
Human
Not specifiedStatin therapy is not warranted for a person with high LDL-cholesterol on a low-carbohydrate diet.
Human
adults with overweight or obesityCarbohydrate intake < 50 g/dayLow-carbohydrate diets lead to greater weight loss and better glucose homeostasis than exercise: a randomized clinical trial.
Human
all participantsNot specified (LCD score calculated based on deciles of energy percentages from macronutrients).The association between low-carbohydrate diet score and metabolic syndrome among Iranian adults.
Human
menNot specified (LCD score calculated based on deciles of energy percentages from macronutrients).The association between low-carbohydrate diet score and metabolic syndrome among Iranian adults.
Human
a proportion of individualsNot specifiedCan low-carbohydrate diets be recommended for reducing cardiovascular risk?
Human
Not specifiedThe effects of low-carbohydrate diets on cardiovascular risk factors: A meta-analysis.
Animal
Not specifiedA low carbohydrate, high protein diet suppresses intratumoral androgen synthesis and slows castration-resistant prostate tumor growth in mice.
Human
mostly obese participants with T2DNot specifiedComparison of the Effectiveness of Low Carbohydrate Versus Low Fat Diets, in Type 2 Diabetes: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Animal
Male APOE*3-Leiden.CETP mice10% inulin (fiber) in the diet.Combination of dietary fiber and exercise training improves fat loss in mice but does not ameliorate MASLD more than exercise alone.
Human
patients with NASHOnce daily for 12 weeks (exact dosage not specified).Treatment efficacy of a probiotic preparation for non-alcoholic steatohepatitis: A pilot trial.
Human
people with elevated blood pressure or lipid levelsMedian of 6 contact hours and 12 sessions over 12 months (varied by low, medium, or high contact time).Behavioral Counseling to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Human
patients with low- to moderate-risk hypercholesterolemia200 mg red yeast rice extract (equivalent to 3 mg monacolins), 500 mg berberine, and 10 mg policosanols once daily after dinner.Efficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols, and Berberine) in Patients with Low-Moderate Risk Hypercholesterolemia: A Double-Blind, Placebo-Controlled Study.
Human
1615 participants in a 10-day residential dietary intervention programAd libitum consumption of a low-fat (≤10% of calories), high-carbohydrate (~80% of calories), moderate-sodium, purely plant-based diet.Effects of 7 days on an ad libitum low-fat vegan diet: the McDougall Program cohort.
Human
sedentary obese older adults3 oz (85 g) or 6 oz (170.1 g) of lean fresh beef daily within a standardized calorie-restricted DASH-like diet.Cardiometabolic Changes in Response to a Calorie-Restricted DASH Diet in Obese Older Adults.
Animal
Hanwoo steers0.5% of alcohol-fermented feed (AFF).Effect of soy lecithin on total cholesterol content, fatty acid composition and carcass characteristics in the Longissimus dorsi of Hanwoo steers (Korean native cattle).
Human
women with overweight/obesity50 g of Kashk dailyEffect of a low energy diet, containing a high protein, probiotic condensed yogurt, on biochemical and anthropometric measurements among women with overweight/obesity: A randomised controlled trial.
Human
healthy and unhealthy adultsNot specifiedPaleolithic Diet-Effect on the Health Status and Performance of Athletes?
Human
healthy and unhealthy adultsNot specifiedPaleolithic Diet-Effect on the Health Status and Performance of Athletes?
Human
healthy and unhealthy adultsNot specifiedPaleolithic Diet-Effect on the Health Status and Performance of Athletes?
Human
healthy and unhealthy adultsNot specifiedPaleolithic Diet-Effect on the Health Status and Performance of Athletes?
Animal
rats0.5 mL/kgThe Impact of Dietary Consumption of Palm Oil and Olive Oil on Lipid Profile and Hepatocyte Injury in Hypercholesterolemic Rats.
Animal
rats0.5 mL/kgThe Impact of Dietary Consumption of Palm Oil and Olive Oil on Lipid Profile and Hepatocyte Injury in Hypercholesterolemic Rats.
Animal
rats0.5 mL/kgThe Impact of Dietary Consumption of Palm Oil and Olive Oil on Lipid Profile and Hepatocyte Injury in Hypercholesterolemic Rats.
Animal
rats0.5 mL/kgThe Impact of Dietary Consumption of Palm Oil and Olive Oil on Lipid Profile and Hepatocyte Injury in Hypercholesterolemic Rats.
Animal
rat modelCholesterol intake and statin use regulate neuronal G protein-gated inwardly rectifying potassium channels.
Animal
ratsNot specifiedLipid-lowering effect of Rhus coriaria L. (sumac) fruit extract in hypercholesterolemic rats.
Animal
ratsNot specified (study mentions "Dill tablet" but does not detail dosage).Dill tablet and Ocimum basilicum aqueous extract: Promising therapeutic agents for improving cognitive deficit in hypercholesterolemic rats.
Animal
ratsPolysaccharide from fuzi (FPS) prevents hypercholesterolemia in rats.
Animal
miceEffects of statins and cholesterol on memory functions in mice.
AnimalMolecular
zebrafishFinal concentration of 0.1 mg/ml in vitro; dosage in vivo not specified.Grape skin and loquat leaf extracts and acai puree have potent anti-atherosclerotic and anti-diabetic activity in vitro and in vivo in hypercholesterolemic zebrafish.
Molecular
hamstersIn vivo biochemical and gene expression analyses of the antioxidant activities and hypocholesterolaemic properties of Tamarindus indica fruit pulp extract.
Human
intervention groupHigh-protein group: 1.3-1.4 g/kg/day; control group: 0.8-1.0 g/kg/day.Effect of an intensive nutrition intervention of a high protein and low glycemic load diet on weight of kidney transplant recipients: a randomized clinical trial.
Animal
rats20% casein diet supplemented with pumpkin protein (exact dosage not specified).Effects of Pumpkin (Cucurbita pepo L.) Seed Protein on Blood Pressure, Plasma Lipids, Leptin, Adiponectin, and Oxidative Stress in Rats with Fructose-Induced Metabolic Syndrome.
Human
Not specified.Improvement of the omega 3 index of healthy subjects does not alter the effects of dietary saturated fats or n-6PUFA on LDL profiles.
Animal
adult male Wistar rats400 mg/kgNicotinamide riboside and dietary restriction effects on gut microbiota and liver inflammatory and morphologic markers in cafeteria diet-induced obesity in rats.
Human
test groupMaximum of 2000 kcal/day.Assessing the effectiveness of a DASH diet in hypertensive patients attending the Ngaoundere Regional Hospital - Cameroon: a case-control study.
Human
patients with moderate hypercholesterolemia5.1 g of psyllium twice daily.Comparison of psyllium hydrophilic mucilloid and cellulose as adjuncts to a prudent diet in the treatment of mild to moderate hypercholesterolemia.